MDR_REPORT_KEY|MDR_TEXT_KEY|TEXT_TYPE_CODE|PATIENT_SEQUENCE_NUMBER|DATE_REPORT|FOI_TEXT|BRAND_NAME|CATALOG_NUMBER|DATE_RECEIVED|DATE_REMOVED_FLAG|DATE_RETURNED_TO_MANUFACTURER|DEVICE_AGE_TEXT|DEVICE_AVAILABILITY|DEVICE_EVALUATED_BY_MANUFACTUR|DEVICE_EVENT_KEY|DEVICE_OPERATOR|DEVICE_REPORT_PRODUCT_CODE|DEVICE_SEQUENCE_NO|EXPIRATION_DATE_OF_DEVICE|GENERIC_NAME|IMPLANT_FLAG|LOT_NUMBER|MANUFACTURER_D_ADDRESS_1|MANUFACTURER_D_ADDRESS_2|MANUFACTURER_D_CITY|MANUFACTURER_D_COUNTRY_CODE|MANUFACTURER_D_NAME|MANUFACTURER_D_POSTAL_CODE|MANUFACTURER_D_STATE_CODE|MANUFACTURER_D_ZIP_CODE|MANUFACTURER_D_ZIP_CODE_EXT|MODEL_NUMBER|OTHER_ID_NUMBER|filter
6275181|65665592|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF WOUND DEHISCENCE EXPOSURE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275184|65665896|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF HEMATOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENT IS ADDRESSED IN DEVICE LABELING HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247187|64666747|D|1||REGULATORY AGENCY REPORTED THAT PHYSICIAN REPORTED BIA-ALCL SIDE IS UNKNOWN EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6247187|64666746|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PATIENT DETAILS IS BEING REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6732140|80678267|N|1||FURTHER INFORMATION FROM THE REPORTER REGARDING RETURN OF THE DEVICE HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING SILICONE GEL FILLED BREAST IMPLANTS ARE PRONE TO UNINTENDED INSTRUMENT TRAUMA DURING IMPLANTATION OR DURING EXPLANTATION NUMBER 1 2 SHELL FAILURE CAN RESULT FROM DAMAGE BY SCALPELS SUTURE NEEDLES HYPODERMIC NEEDLES HEMOSTATS AND ADSON FORCEPS AND HAS BEEN OBSERVED IN EXPLANTED DEVICE SHELLS USING SCANNING ELECTRON MICROSCOPY ALLERGANÂ¿S RETRIEVAL STUDY ANALYSES OF EXPLANTED DEVICES HAVE IDENTIFIED UNINTENDED SURGICAL INSTRUMENT DAMAGE AS ONE POTENTIAL CAUSE OF SHELL FAILURE AND THUS IMPLANT RUPTURE THE PATIENT SHOULD BE TOLD THAT THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGE IN THE IMPLANT SHAPE MAY BE SIGNS OF SYMPTOMATIC RUPTURE OF THE IMPLANT IF THE PATIENT HAS ANY OF THESE SIGNS SHE SHOULD BE TOLD TO REPORT THEM AND POSSIBLY HAVE AN MRI EVALUATION TO SCREEN FOR RUPTURE POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BREAST IMPLANTS ARE NOT LIFETIME DEVICES BREAST IMPLANTS RUPTURE WHEN THE SHELL DEVELOPS A TEAR OR HOLE RUPTURES CAN OCCUR AT ANY TIME AFTER IMPLANTATION BUT THEY ARE MORE LIKELY TO OCCUR THE LONGER THE IMPLANT IS IMPLANTED THE FOLLOWING THINGS MAY CAUSE IMPLANTS TO RUPTURE DAMAGE BY SURGICAL INSTRUMENTS STRESSING THE IMPLANT DURING IMPLANTATION AND WEAKENING IT FOLDING OR WRINKLING OF THE IMPLANT SHELL EXCESSIVE FORCE TO THE CHEST EG DURING CLOSED CAPSULOTOMY WHICH IS CONTRAINDICATED TRAUMA COMPRESSION DURING MAMMOGRAPHIC IMAGING AND SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR OUT OVER TIME LABORATORY STUDIES HAVE IDENTIFIED SOME OF THE CAUSES OF RUPTURE FOR ALLERGANÂ¿S PRODUCT IT IS NOT CONCLUSIVELY KNOWN WHETHER THESE TESTS HAVE IDENTIFIED ALL CAUSES OF RUPTURE LABORATORY STUDIES TO IDENTIFY ANY ADDITIONAL CAUSES OF RUPTURE ARE ONGOING SILICONE GEL FILLED IMPLANT RUPTURES ARE MOST OFTEN SILENT THIS MEANS THAT MOST OF THE TIME NEITHER YOU NOR YOUR PATIENT WILL KNOW IF THE IMPLANT HAS A TEAR OR HOLE IN THE SHELL MRI EXAMINATION IS CURRENTLY THE BEST METHOD TO SCREEN FOR RUPTURE SEE TABLE 3 FOR ADDITIONAL INFORMATION REGARDING MRI SCREENING SOMETIMES THERE ARE SYMPTOMS ASSOCIATED WITH GEL IMPLANT RUPTURE THESE SYMPTOMS INCLUDE HARD KNOTS OR LUMPS SURROUNDING THE IMPLANT OR IN THE ARMPIT CHANGE OR LOSS OF SIZE OR SHAPE OF THE BREAST OR IMPLANT PAIN TINGLING SWELLING NUMBNESS BURNING AND HARDENING OF THE BREAST WHEN MRI SIGNS OF RUPTURE ARE FOUND SUCH AS SUBCAPSULAR LINES CHARACTERISTIC FOLDED WAVY LINES TEARDROP SIGN KEYHOLE SIGN NOOSE SIGN OR IF THERE ARE SIGNS OR SYMPTOMS OF RUPTURE YOU SHOULD REMOVE THE IMPLANT AND ANY GEL YOU DETERMINE YOUR PATIENT HAS WITH OR WITHOUT REPLACEMENT OF THE IMPLANT IT ALSO MAY BE NECESSARY TO REMOVE THE TISSUE CAPSULE THERE ARE ALSO CONSEQUENCES OF RUPTURE IF RUPTURE OCCURS SILICONE GEL MAY EITHER REMAIN WITHIN THE SCAR TISSUE CAPSULE SURROUNDING THE IMPLANT INTRACAPSULAR RUPTURE MOVE OUTSIDE THE CAPSULE EXTRACAPSULAR RUPTURE OR MOVE OUTSIDE THE BREAST GEL MIGRATION THERE IS ALSO A POSSIBILITY THAT RUPTURE MAY PROGRESS FROM INTRACAPSULAR TO EXTRACAPSULAR AND BEYOND IN ALLERGANÂ¿S CORE STUDY THERE WAS A MRI SCREENING COHORT WHO HAD REGULAR MRIS TO SCREEN FOR BREAST IMPLANT RUPTURE WHETHER OR NOT THEY WERE SYMPTOMATIC IE MRI COHORT AND A NON-MRI SCREENING COHORT WHO WERE NOT SCREENED WITH BREAST IMPLANT MRIS IE NON-MRI COHORT THE RUPTURE RATES IN THE MRI COHORTS WERE 93 FOR PRIMARY AUGMENTATION 54 FOR REVISION-AUGMENTATION 354 FOR PRIMARY RECONSTRUCTION AND 0 FOR REVISION-RECONSTRUCTION THE RUPTURE RATE FOR THE WHOLE MRI COHORT IN THE CORE STUDY INCLUDING AUGMENTATION REVISION-AUGMENTATION RECONSTRUCTION AND REVISION-RECONSTRUCTION PATIENTS THROUGH 10 YEARS WAS 130 FOR PATIENTS AND 77 FOR IMPLANTS ACROSS ALL PATIENTS IN THE CORE STUDY ALL RUPTURES WERE INTRACAPSULAR WITH THE EXCEPTION OF 3 CASES OF EXTRACAPSULAR GEL ONE RUPTURE PROGRESSED TO EXTRACAPSULAR GEL FOLLOWING EXPLORATORY SURGERY TO CONFIRM THE RUPTURE AND THEN IMPLANT REPLACEMENT WAS DELAYED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/21/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6726972|80492266|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE A REVIEW OF DEVICE HISTORY RECORD HAS BEEN INITIATED IF ANY NEW CHANGED OR CORRECTION INFORMATION IS NOTED A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED|STYLE 68 SALINE FILLED BREAST IMPLANT|68-300|07/19/2017||||N|R||0HP|FWM|1.0|02/07/2017|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2422411|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6747801|81202545|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN COMPLETED NO DEVIATIONS OR NON-CONFORMANCES NOTED DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY ADDITIONAL COMPLICATIONS Â¿ AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS|STYLE 468 SALINE FILLED BREAST IMPLANT|468-270|07/27/2017||||N|R||0HP|FWM|1.0|02/03/2002|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||533853|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6736742|80822389|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE POSSIBLE ADVERSE EVENTS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATIONIMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY RUPTURE Â¿ BREAST IMPLANTS ARE NOT LIFETIME DEVICES Â¿ BREAST IMPLANTS RUPTURE WHEN THE SHELL DEVELOPS A TEAR OR HOLE RUPTURES CAN OCCUR AT ANY TIME AFTER IMPLANTATION BUT THEY ARE MORE LIKELY TO OCCUR THE LONGER THE IMPLANT IS IMPLANTED Â¿ THE FOLLOWING THINGS MAY CAUSE IMPLANTS TO RUPTURE DAMAGE BY SURGICAL INSTRUMENTS STRESSING THE IMPLANT DURING IMPLANTATION AND WEAKENING IT FOLDING OR WRINKLING OF THE IMPLANT SHELL EXCESSIVE FORCE TO THE CHEST EG DURING CLOSED CAPSULOTOMY WHICH IS CONTRAINDICATED TRAUMA COMPRESSION DURING MAMMOGRAPHIC IMAGING AND SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR OUT OVER TIME LABORATORY STUDIES HAVE IDENTIFIED SOME OF THE CAUSES OF RUPTURE FOR ALLERGANÂ¿S PRODUCT IT IS NOT CONCLUSIVELY KNOWN WHETHER THESE TESTS HAVE IDENTIFIED ALL CAUSES OF RUPTURE LABORATORY STUDIES TO IDENTIFY ANY ADDITIONAL CAUSES OF RUPTURE ARE ONGOING Â¿ SILICONE GEL FILLED IMPLANT RUPTURES ARE MOST OFTEN SILENT THIS MEANS THAT MOST OF THE TIME NEITHER YOU NOR YOUR PATIENT WILL KNOW IF THE IMPLANT HAS A TEAR OR HOLE IN THE SHELL MRI EXAMINATION IS CURRENTLY THE BEST METHOD TO SCREEN FOR RUPTURE Â¿ SOMETIMES THERE ARE SYMPTOMS ASSOCIATED WITH GEL IMPLANT RUPTURE THESE SYMPTOMS INCLUDE HARD KNOTS OR LUMPS SURROUNDING THE IMPLANT OR IN THE ARMPIT CHANGE OR LOSS OF SIZE OR SHAPE OF THE BREAST OR IMPLANT PAIN TINGLING SWELLING NUMBNESS BURNING AND HARDENING OF THE BREAST Â¿ WHEN MRI SIGNS OF RUPTURE ARE FOUND SUCH AS SUBCAPSULAR LINES CHARACTERISTIC FOLDED WAVY LINES TEARDROP SIGN KEYHOLE SIGN NOOSE SIGN OR IF THERE ARE SIGNS OR SYMPTOMS OF RUPTURE YOU SHOULD REMOVE THE IMPLANT AND ANY GEL YOU DETERMINE YOUR PATIENT HAS WITH OR WITHOUT REPLACEMENT OF THE IMPLANT IT ALSO MAY BE NECESSARY TO REMOVE THE TISSUE CAPSULE Â¿ THERE ARE ALSO CONSEQUENCES OF RUPTURE IF RUPTURE OCCURS SILICONE GEL MAY EITHER REMAIN WITHIN THE SCAR TISSUE CAPSULE SURROUNDING THE IMPLANT INTRACAPSULAR RUPTURE MOVE OUTSIDE THE CAPSULE EXTRACAPSULAR RUPTURE OR MOVE OUTSIDE THE BREAST GEL MIGRATION THERE IS ALSO A POSSIBILITY THAT RUPTURE MAY PROGRESS FROM INTRACAPSULAR TO EXTRACAPSULAR AND BEYOND|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/24/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||nan|||||||True
6275115|65665901|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON B6 2016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF INFECTION AND WOUND DEHISCENCE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS IS ADDRESSED IN DEVICE LABELING INFECTION AROUND A BREAST IMPLANT MAY OCCUR WITHIN DAYS WEEKS OR EVEN YEARS AFTER SURGERY SIGNS OF ACUTE INFECTION REPORTED IN ASSOCIATION WITH IMPLANTS INCLUDE ERYTHEMA TENDERNESS FLUID ACCUMULATION PAIN AND FEVER ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION INFECTION THAT IS UNRESPONSIVE TO TREATMENT MAY REQUIRE IMPLANT REMOVAL VERY RARELY TOXIC SHOCK SYNDROME HAS BEEN REPORTED AS A POSSIBLE COMPLICATION OF BREAST IMPLANT SURGERY AND MAY ALSO BE ASSOCIATED WITH OTHER TYPES OF IMPLANT SURGERY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275192|65664980|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF BURN IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6341238|67800491|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED FOR DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6341238|67800492|D|1||PHYSICIAN REPORTS BREAST IMPLANT ASSOCIATED ALCL ON THE RIGHT SIDE DEVICE WAS EXPLANTED AS PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED TO CONFIRM ALCL DIAGNOSIS THIS EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|02/17/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247063|64661472|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAVE BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME THE EVENTS OF SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6247063|64661472|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAVE BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME THE EVENTS OF SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247160|68260911|D|1||PHYSICIAN REPORTS THE PATIENT PRESENTED TO ER WITH ANEMIA AND WEIGHT LOSS IN B6 2016 PATIENT WAS DIAGNOSED WITH BIA-ALCL ON B6 2016 PHYSICIAN REPORTED RIGHT SIDE RUPTURE AND RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2017-00006 FOR THE LEFT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247160|64710081|D|1||PHYSICIAN REPORTS THE PATIENT PRESENTED TO ER WITH ANEMIA AND WEIGHT LOSS IN B6 2016 PATIENT WAS DIAGNOSED WITH BIA-ALCL ON B6 2016 PHYSICIAN REPORTED RIGHT SIDE RUPTURE AND RIGHT SIDE CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2017-00006 FOR THE LEFT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6736724|80857070|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE POSSIBLE ADVERSE EVENTS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATIONIMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY RUPTURE BREAST IMPLANTS ARE NOT LIFETIME DEVICES BREAST IMPLANTS RUPTURE WHEN THE SHELL DEVELOPS A TEAR OR HOLE RUPTURES CAN OCCUR AT ANY TIME AFTER IMPLANTATION BUT THEY ARE MORE LIKELY TO OCCUR THE LONGER THE IMPLANT IS IMPLANTED THE FOLLOWING THINGS MAY CAUSE IMPLANTS TO RUPTURE DAMAGE BY SURGICAL INSTRUMENTS STRESSING THE IMPLANT DURING IMPLANTATION AND WEAKENING IT FOLDING OR WRINKLING OF THE IMPLANT SHELL EXCESSIVE FORCE TO THE CHEST EG DURING CLOSED CAPSULOTOMY WHICH IS CONTRAINDICATED TRAUMA COMPRESSION DURING MAMMOGRAPHIC IMAGING AND SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR OUT OVER TIME LABORATORY STUDIES HAVE IDENTIFIED SOME OF THE CAUSES OF RUPTURE FOR ALLERGANÂ¿S PRODUCT IT IS NOT CONCLUSIVELY KNOWN WHETHER THESE TESTS HAVE IDENTIFIED ALL CAUSES OF RUPTURE LABORATORY STUDIES TO IDENTIFY ANY ADDITIONAL CAUSES OF RUPTURE ARE ONGOING SILICONE GEL FILLED IMPLANT RUPTURES ARE MOST OFTEN SILENT THIS MEANS THAT MOST OF THE TIME NEITHER YOU NOR YOUR PATIENT WILL KNOW IF THE IMPLANT HAS A TEAR OR HOLE IN THE SHELL MRI EXAMINATION IS CURRENTLY THE BEST METHOD TO SCREEN FOR RUPTURE SOMETIMES THERE ARE SYMPTOMS ASSOCIATED WITH GEL IMPLANT RUPTURE THESE SYMPTOMS INCLUDE HARD KNOTS OR LUMPS SURROUNDING THE IMPLANT OR IN THE ARMPIT CHANGE OR LOSS OF SIZE OR SHAPE OF THE BREAST OR IMPLANT PAIN TINGLING SWELLING NUMBNESS BURNING AND HARDENING OF THE BREAST WHEN MRI SIGNS OF RUPTURE ARE FOUND SUCH AS SUBCAPSULAR LINES CHARACTERISTIC FOLDED WAVY LINES TEARDROP SIGN KEYHOLE SIGN NOOSE SIGN OR IF THERE ARE SIGNS OR SYMPTOMS OF RUPTURE YOU SHOULD REMOVE THE IMPLANT AND ANY GEL YOU DETERMINE YOUR PATIENT HAS WITH OR WITHOUT REPLACEMENT OF THE IMPLANT IT ALSO MAY BE NECESSARY TO REMOVE THE TISSUE CAPSULE THERE ARE ALSO CONSEQUENCES OF RUPTURE IF RUPTURE OCCURS SILICONE GEL MAY EITHER REMAIN WITHIN THE SCAR TISSUE CAPSULE SURROUNDING THE IMPLANT INTRACAPSULAR RUPTURE MOVE OUTSIDE THE CAPSULE EXTRACAPSULAR RUPTURE OR MOVE OUTSIDE THE BREAST GEL MIGRATION THERE IS ALSO A POSSIBILITY THAT RUPTURE MAY PROGRESS FROM INTRACAPSULAR TO EXTRACAPSULAR AND BEYOND|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/24/2017||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||nan|||||||True
6617685|76841698|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE THE REPORTED EVENTS OF LYMPHOMA SEROMA AND EDEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS REPORTED EVENTS ARE ADDRESSED IN THE LABELING THE PATIENT SHOULD BE TOLD THAT THE PRESENCE OF LUMPS PERSISTENT PAIN SWELLING HARDENING OR CHANGE IN THE IMPLANT SHAPE MAY BE SIGNS OF SYMPTOMATIC RUPTURE OF THE IMPLANT IF THE PATIENT HAS ANY OF THESE SIGNS SHE SHOULD BE TOLD TO REPORT THEM AND POSSIBLY HAVE AN MRI EVALUATION TO SCREEN FOR RUPTURE POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY SIMILAR TO A BRUISE A SEROMA OCCURS WHEN THE WATERY PORTION OF THE BLOOD COLLECTS AROUND A SURGICAL INCISION OR AROUND A BREAST IMPLANT AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHY CHEST WALL DEFORMITY ALCL IS NOT BREAST CANCER IT IS A RARE TYPE OF NON-HODGKINÂ¿S LYMPHOMA A CANCER INVOLVING THE CELLS OF THE IMMUNE SYSTEM BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|06/07/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275196|65672814|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF NECROSIS IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENT IS ADDRESSED IN DEVICE LABELING Â¿NECROSIS MAY INHIBIT WOUND HEALING AND REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION PERMANENT SCAR DEFORMITY MAY OCCUR AS A RESULT OF NECROSIS PLACEMENT EXPANSION AND PRESSURE OF THE REMOTE INJECTION SITE IN THE NATRELLE 150 MAY INDUCE NECROSIS PARTICULARLY WITH UNSUITABLE SKIN FLAPS DO NOT USE MICROWAVE DIATHERMY IN PATIENTS WITH BREAST IMPLANTS MICROWAVE DIATHERMY HAS BEEN REPORTED TO CAUSE TISSUE NECROSIS SKIN EROSION AND IMPLANT EXTRUSIONÂ¿|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6739576|80876927|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE THE EVENT OF CAPSULAR CONTRACTURE IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES THE REPORTED EVENT AS FOLLOWS POSSIBLE ADVERSE EVENTS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDEIMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY CAPSULAR CONTRACTURE PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PATIENTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PATIENTS CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT RUPTURE AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|07/25/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||nan|||||||True
6247152|64673721|D|1||PHYSICIAN REPORTS THE PATIENT PRESENTED TO ER WITH ANEMIA AND WEIGHT LOSS IN B6 2016 PATIENT WAS DIAGNOSED WITH BIA-ALCL ON B6 2016 PHYSICIAN REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED PATIENT WAS ADDITIONALLY FOUND TO HAVE A LEFT AXILLARY LYMPH NODE WITH LYMPHOMA CELLS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS MEDWATCH REPRESENTS THE LEFT SIDE SEE MFR  9617229-2017-00007 FOR THE RIGHT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247152|68396193|D|1||PHYSICIAN REPORTS THE PATIENT PRESENTED TO ER WITH ANEMIA AND WEIGHT LOSS IN B6 2016 PATIENT WAS DIAGNOSED WITH BIA-ALCL ON B6 2016 PHYSICIAN REPORTED LEFT SIDE CAPSULAR CONTRACTURE BAKER GRADE NOT SPECIFIED PATIENT WAS ADDITIONALLY FOUND TO HAVE A LEFT AXILLARY LYMPH NODE WITH LYMPHOMA CELLS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS MEDWATCH REPRESENTS THE LEFT SIDE SEE MFR  9617229-2017-00007 FOR THE RIGHT SIDE|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6323298|67155236|N|1||B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS DEVICE CURRENTLY REMAINS IMPLANTED AND WILL BE REQUESTED AFTER PLANNED EXPLANT THE EVENTS OF LYMPHOMA PLEURAL EFFUSION LATE SEROMA COLLAPSED IPSILATERAL LUNG LYMPHADENOPATHY BREAST LUMPS AND DYSPNEA AND ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING DEVICE DETAILS IS BEING REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY BASED ON INFORMATION REPORTED TO FDA AND FOUND IN MEDICAL LITERATURE A POSSIBLE ASSOCIATION HAS BEEN IDENTIFIED BETWEEN BREAST IMPLANTS AND THE RARE DEVELOPMENT OF ANAPLASTIC LARGE CELL LYMPHOMA ALCL A TYPE OF NON-HODGKINÂ¿S LYMPHOMA WOMEN WITH BREAST IMPLANTS MAY HAVE A VERY SMALL BUT INCREASED RISK OF DEVELOPING ALCL IN THE FLUID OR SCAR CAPSULE ADJACENT TO THE IMPLANT ALCL HAS BEEN REPORTED GLOBALLY IN PATIENTS WITH AN IMPLANT HISTORY THAT INCLUDES ALLERGANÂ¿S AND OTHER MANUFACTURERSÂ¿ BREAST IMPLANTS YOU SHOULD CONSIDER THE POSSIBILITY OF ALCL WHEN YOU HAVE A PATIENT WITH LATE ONSET PERSISTENT PERI-IMPLANT SEROMA IN SOME CASES PATIENTS PRESENTED WITH CAPSULAR CONTRACTURE OR MASSES ADJACENT TO THE BREAST IMPLANT WHEN TESTING FOR ALCL COLLECT FRESH SEROMA FLUID AND REPRESENTATIVE PORTIONS OF THE CAPSULE AND SEND FOR PATHOLOGY TESTS TO RULE OUT ALCL IF YOUR PATIENT IS DIAGNOSED WITH PERI-IMPLANT ALCL DEVELOP AN INDIVIDUALIZED TREATMENT PLAN IN COORDINATION WITH A MULTI-DISCIPLINARY CARE TEAM BECAUSE OF THE SMALL NUMBER OF CASES WORLDWIDE THERE IS NO DEFINED CONSENSUS TREATMENT REGIMEN FOR PERI-IMPLANT ALCL AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY|INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT|SSF370|02/10/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6275189|65664734|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF SEROMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENT IS ADDRESSED IN DEVICE LABELING HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6727132|80491672|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE THE EVENTS OF Â¿SUFFERED BODILY INJURY AND RESULTING PAIN AND SUFFERING MENTAL ANGUISH DISABILITY DISFIGUREMENT AND LOSS OF THE CAPACITY FOR THE ENJOYMENT OF LIFE Â¿Â¿ IT WAS REPORTED THAT Â¿THE LOSSES ARE PERMANENT OR CONTINUING IN NATURE AND PATIENT WILL SUFFER THEM IN THE FUTUREÂ¿ ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS A REVIEW OF DEVICE HISTORY RECORD HAS BEEN INITIATED IF ANY NEW CHANGED OR CORRECTION INFORMATION IS NOTED A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED|STYLE 68 SALINE FILLED BREAST IMPLANT|68-300|07/19/2017||||N|R||0HP|FWM|1.0|01/23/2017|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2422565|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275180|65664586|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF WOUND DEHISCENCE EXPOSURE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6747806|81230837|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN COMPLETED NO DEVIATIONS OR NON-CONFORMANCES NOTED DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY ADDITIONAL COMPLICATIONS Â¿ AFTER BREAST IMPLANT SURGERY THE FOLLOWING MAY OCCUR ANDOR PERSIST WITH VARYING INTENSITY ANDOR FOR A VARYING LENGTH OF TIME HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING AND BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS CAN FORM IN THE TISSUE CAPSULE SURROUNDING THE IMPLANT WITH SYMPTOMS THAT MAY INCLUDE PAIN AND FIRMNESS LYMPHADENOPATHY HAS ALSO BEEN REPORTED IN SOME WOMEN WITH IMPLANTS|STYLE 468 SALINE FILLED BREAST IMPLANT|468-270|07/27/2017||||N|R||0HP|FWM|1.0|07/14/2001|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||530578|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6749023|81231005|N|1||INFORMATION CONTAINED IN THIS REPORT WAS PREVIOUSLY SUBMITTED THROUGH ASR ON 22JUL2017 A REVIEW OF DEVICE HISTORY RECORD HAS BEEN INITIATED IF ANY NEW CHANGED OR CORRECTION INFORMATION IS NOTED A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED DEVICE EVALUATION VISUAL ANALYSIS OF THE RETURNED DEVICE IDENTIFIED WHITE PARTICLES IN INNER SURFACE A LEAK TEST WAS PERFORMED WHICH DID NOT IDENTIFY OPENINGS ON THE DEVICE MICROSCOPIC ANALYSIS WAS PERFORMED WHICH DID NOT IDENTIFY ADDITIONAL OBSERVATIONS A FILL INSPECTION WAS PERFORMED AND IDENTIFIED NO BLOCKAGE IN VALVE BASED ON THE DEVICE ANALYSIS THE FINAL ASSESSMENT IS - NO ISSUES FOUND RELATED WITH THE MANUFACTURING PROCESS - INTACT AND FUNCTIONAL - NOT WERE FOUND OPENINGS ON THE DEVICE AND NOT FOUND POSSIBLE DAMAGE ON VALVE FOR THIS REASON I CANNOT CONFIRM THE DEFLATION DEVICE LABELING POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SALINE-FILLED BREAST IMPLANT SURGERY INCLUDE REOPERATION PAIN WRINKLING ASYMMETRY IMPLANT PALPABILITYVISIBILITY IMPLANT REMOVAL CAPSULAR CONTRACTURE CHANGES IN NIPPLE AND BREAST SENSATION IMPLANT DISPLACEMENTMIGRATION IMPLANT DEFLATION SCARRING INFECTION HEMATOMASEROMA BREASTFEEDING COMPLICATIONS IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY COMPLICATIONS DEFLATION Â¿ BREAST IMPLANTS ARE NOT LIFETIME DEVICES SALINE BREAST IMPLANTS DEFLATE WHEN THE SHELL DEVELOPS A TEAR OR HOLE DEFLATION CAN OCCUR AT ANY TIME AFTER IMPLANTATION BUT THEY ARE MORE LIKELY TO OCCUR THE LONGER THE IMPLANT IS IMPLANTED THE FOLLOWING THINGS MAY CAUSE IMPLANTS TO DEFLATE DAMAGE BY SURGICAL INSTRUMENTS FOLDING OR WRINKLING OF THE IMPLANT SHELL EXCESSIVE FORCE TO THE CHEST EG DURING CLOSED CAPSULOTOMY WHICH IS CONTRAINDICATED TRAUMA COMPRESSION DURING MAMMOGRAPHIC IMAGING AND SEVERE CAPSULAR CONTRACTURE BREAST IMPLANTS MAY ALSO SIMPLY WEAR OUT OVER TIME LABORATORY STUDIES HAVE IDENTIFIED SOME OF THE CAUSES OF DEFLATION FOR ALLERGANÂ¿S PRODUCT HOWEVER IT IS NOT CONCLUSIVELY KNOWN WHETHER THESE TESTS HAVE IDENTIFIED ALL CAUSES OF DEFLATION|STYLE 68 SALINE FILLED BREAST IMPLANT|68HP-425|07/27/2017||06/30/2017||R|Y||0HP|FWM|1.0|12/18/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1384339|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275148|65665652|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF NECROSIS IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENT IS ADDRESSED IN DEVICE LABELING Â¿NECROSIS MAY INHIBIT WOUND HEALING AND REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION PERMANENT SCAR DEFORMITY MAY OCCUR AS A RESULT OF NECROSIS PLACEMENT EXPANSION AND PRESSURE OF THE REMOTE INJECTION SITE IN THE NATRELLE 150 MAY INDUCE NECROSIS PARTICULARLY WITH UNSUITABLE SKIN FLAPS DO NOT USE MICROWAVE DIATHERMY IN PATIENTS WITH BREAST IMPLANTS MICROWAVE DIATHERMY HAS BEEN REPORTED TO CAUSE TISSUE NECROSIS SKIN EROSION AND IMPLANT EXTRUSIONÂ¿|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6450784|71555046|D|1||IMPLANT RUPTURED FOLLOWING MAMMOGRAM FELT PAIN IN RIGHT BREAST AFTER MAMMOGRAM I NOTICED IT GETTING SMALLER OVER THE NEXT FEW WEEKS I WAS IN DENIAL THAT THERE WAS A PROBLEM BECAUSE I DONT REALLY WANT TO HAVE SURGERY AGAIN SAW THE PLASTIC SURGEON TO CONFIRM SUSPICIONS AND HE SAID YES THE IMPLANT HAS SOME SALINE IN THERE BUT IT IS CLEARLY RUPTURED AND HALF THE SIZE|MCGHAN SALINE BREAST IMPLANT||03/29/2017||||Y|I||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE|||||||INAMED/ALLERGAN|||||||True
6739572|80877777|N|1||ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL EVENT PRODUCT OR PATIENT DETAILS ARE NOT ATTAINABLE THE EVENT OF CAPSULAR CONTRACTURE IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT DEVICE LABELING ADDRESSES THE REPORTED EVENT AS FOLLOWS POSSIBLE ADVERSE EVENTS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDEIMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY CAPSULAR CONTRACTURE Â¿ PATIENTS SHOULD BE ADVISED THAT CAPSULAR CONTRACTURE MAY BE MORE COMMON FOLLOWING INFECTION HEMATOMA AND SEROMA AND THE CHANCE OF IT HAPPENING MAY INCREASE OVER TIME Â¿ CAPSULAR CONTRACTURE OCCURS MORE COMMONLY IN REVISION PATIENTS THAN IN PRIMARY AUGMENTATION OR RECONSTRUCTION PATIENTS Â¿ CAPSULAR CONTRACTURE IS ALSO A RISK FACTOR FOR IMPLANT RUPTURE AND IT IS ONE OF THE MOST COMMON REASONS FOR REOPERATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|07/25/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275175|65664905|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON B6 2016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF WOUND DEHISCENCE IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275110|65665527|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF HEMATOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENT IS ADDRESSED IN DEVICE LABELING HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275190|65665389|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF INFECTION AND WOUND DEHISCENCE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS IS ADDRESSED IN DEVICE LABELING INFECTION AROUND A BREAST IMPLANT MAY OCCUR WITHIN DAYS WEEKS OR EVEN YEARS AFTER SURGERY SIGNS OF ACUTE INFECTION REPORTED IN ASSOCIATION WITH IMPLANTS INCLUDE ERYTHEMA TENDERNESS FLUID ACCUMULATION PAIN AND FEVER ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION INFECTION THAT IS UNRESPONSIVE TO TREATMENT MAY REQUIRE IMPLANT REMOVAL VERY RARELY TOXIC SHOCK SYNDROME HAS BEEN REPORTED AS A POSSIBLE COMPLICATION OF BREAST IMPLANT SURGERY AND MAY ALSO BE ASSOCIATED WITH OTHER TYPES OF IMPLANT SURGERY|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6275198|65663535|N|1||ARTICLE CITATION Â¿TWO-STAGE IMPLANT-BASED BREAST RECONSTRUCTION COMPARED WITH IMMEDIATE ONE-STAGE IMPLANT-BASED BREAST RECONSTRUCTION AUGMENTED WITH AN ACELLULAR DERMAL MATRIX AN OPEN-LABEL PHASE 4 MULTICENTRE RANDOMISED CONTROLLED TRIALÂ¿ BY RIEKY E G DIKMANS VERA L NEGENBORN MARK-BRAM BOUMAN HAY A H WINTERS JOS W R TWISK P QUINTEN RUHÃ MARC A M MUREAU JAN MAERTEN SMIT STEFANIA TUINDER YASSIR ELTAHIR NICOLE A POSCH JOSEPHINA M VAN STEVENINCK-BARENDS MARLEEN A MEESTERS-CABERG RENÃ R W J VAN DER HULST MARCO J P F RITT MARGRIET G MULLENDER PUBLISHED IN THE LANCET ONCOLOGY ONLINE ON 12212016 IT IS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS IS ADDRESSED IN DEVICE LABELING GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/24/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
16635|10169|D|1||RPTR UNDERWENT SURGERY TO HAVE SILICONE INFLATABLE IMPLANTS SALINE IN 174 THIS WAS DONE TO CORRECT THE EFFECTS OF AN ASYMMETRICAL CHEST WALL A BIRTH DEFECT IT WAS ONLY A FEW WEEKS AGO THAT RPTR WAS ABLE TO CONFIRM 16 YEARS OF ILLNESS DUE TO THESE IMPLANTS IN SIXTEEN YEARS NOT ONE DR EVER TOLD HER THAT IMPLANTS COULD BE CAUSING SYMPTOMS OF MUSCLE PAIN ELEVATED LIVER COUNTS JOINT PAIN AND STIFFNESS SORE LYMPH NODES PULMONARY IRREGULARITIES WEAKNESS AND FATIGUE HEADACHES RASH PHOTOSENSITIVITY NUMBNESS IN LEG AND BACK LOW GRADE FEVERS AND DEPRESSION AND ANXIETY OVER MEMORY PROBLEMS ALL OF THESE SYMPTOMS CAN BE TRACED THROUGH RPTRS MEDICAL RECORD GOING BACK TO 1978 THE ONLY PUBLIC RECOGNITION OF THESE SYMPTOMS HAS BEEN RELATED TO THE LEAKING OF GEL IMPLANTS THE SILICONE SACKS CAUSE JUST AS MUCH OF A PROBLEM IN 1985 RPTR HAD A FULL BLOWN AUTOIMMUNE RESPONSE WITH EVERY SYMPTOM MENTIONED EARLIER IN THIS LETTER RPTR LOST OVER A YEAR OF HER LIFE SHE COULDNT TAKE CARE OF HER SMALL CHILDREN OR GET OUT OF BED FOR MORE THAN A SHORT TIME SHE WENT TO MORE THAN EIGHT DRS THAT YEAR ALONE MOST BLOOD SAMPLES WERE WITHIN NORMAL RANGE THE SYMPTOMS PERSISTED OFF AND ON FOR YEARS AND TO THIS DAY RPTR HAS LEARNED TO LIVE WITH THEM IT HAS BEEN A TREMENDOUS SHOCK FOR RPTR TO REALIZE AFTER READING CASE STUDIES OF WOMEN WITH NOT ONLY GEL FILLED BUT ALSO SALINE-FILLED IMPLANTS THAT THEIR SYMPTOMS ARE JUST LIKE HERS RPTR WAS NEVER TOLD EVEN AFTER FIVE MAMMOGRAMS THAT IT IS NOT POSSIBLE TO DETECT ALL CANCERS WITH THIS TEST DR NEVER TOLD HER THE MAMMOGRAM REPORTS STATED A CONTAINED RUPTURE NO ONE TOLD HER HER BREAST PAIN WAS FROM THE SURGERY THAT THE IMPLANTS MAY NEED TO BE REPLACED BECOME HARD AND UNCOMFORTABLE LIKE ROCKS|SILICONE INFLATABLE BREAST IMPLANT||06/30/1994|B|||*||16568.0|*|FWM|1.0||SILICONE GEL BREAST IMPLANT|Y|||||*|UNKNOWN|||||||True
28147|19137|D|1||RPTRS RIGHT IMPLANT WAS BLEEDING THROUGH ENVELOPE AND REQUIRED CLOSED  CAPSULOTOMY ONE TIME LEFT IMPLANT RUPTURED SHE HAD NUMBNESS IN THE SURGICAL AREA SHE WAS HUGGING HER HUSBAND IN SPRING 1985 WHEN SHE FELT A POP AT HER LEFT BREAST SHE ASSUMED IT WAS THE SCAR TISSUE SURROUNDING THE IMPLANT THAT RELEASD BECAUSE SHE WAS TOLD THEY WOULD NOT RUPTURE FROM EVERYDAY SITUATIONS THERE WERE NO CHANGES IN THE BREAST AND SHE SOON FORGOT ALL ABOUT IT IT CAME TO HER ATTENTION YEARS LATER THAT IMPLANTS WERE RUPTURING AND SHE STARTED TO SUSPECT IT AS A CAUSE FOR HER FAILING HEALTH IN THE SAME TIME FRAME AS THE POP SHE STARTED WITH SUDDEN UNEXPLAINED COMPLETE AND TOTAL NUMBNESS IN BOTH ARMS AND HANDS DURING THE NIGHT AND PINS AND NEEDLES DURING THE DAY SHE ALSO STARTED TO GET STABBING PAINS IN THE AREA OF THE OUTER CORNER OF HER LEFT EYE OVER TIME IT DEVELOPED INTO A HEADACHE THAT WAS CONSTANT DAY AND NIGHT FOR EIGHT YEARS FOR ALL THOSE YEARS SHE NEVER GOT A FULL NIGHTS SLEEP SO SHE DID NOT KNOW IF THE FATIGUE WAS ALSO A SYMPTOM OR A RESULT OF THE LACK OF SLEEP THE TOTAL NUMBNESS OF HER ARMS AND HANDS HAS SUBSIDED BUT NOW SHE HAS MORE PINS AND NEEDLES PAIN AND BURNING PAIN THEY WILL GO COMPLETELY NUMB ON OCCASION MOSTLY DURING SLEEP THE DOCTORS SAID IT WAS BILATERAL CARPAL TUNNEL SYNDROME SHE HAD NERVE CONDUCTION STUDIES TO CONFIRM THE PROBLEM SURGERY WAS PERFORMED ON HER RIGHT HAND BUT THERE BUT THERE HAS BEEN NO IMPROVEMENT IN 42493 SHE HAD TO HAVE HER OVARIES REMOVED BECAUSE OF A LARGE CYST SHE REQUESTED THAT THE LAB SCREEN FOR SILICONE BECAUSE SHE WAS SO CERTAIN IT WAS THE CAUSE OF HER HEALTH PROBLEMS THE LAB DID FIND  SILICONE IN THE CYST SHE HAD HER IMPLANTS AND SCAR TISSUE REMOVED 52792 THE LEFT IMPLANT HAD A LARGE RUPTURE RECONSTRUCTION SURGERY WAS PERFORMED A YEAR OR MORE AFTER EXPLANTATION HER HEADACHES FINALLY LET UP ENOUGH SO THAT SHE WAS ABLE TO SLEEP MOST NIGHTS HER MAJOR PROBLEMS THESE DAYS ARE HER ARMS AND HANDS THEY BURN AND HURT ALL THE TIME HER JOINTS HAVE ACHED FOR A LONG TIME BUT THEY SEEM TO BE GETTING WORSE ESPECIALLY HER FINGER JOINTS ELBOWS WRISTS AND LEFT SHOULDER THE DOCTORS HAVE MENTIONED TENDONITIS AND FIBROMYALGIA SHE IS STILL HAVING PINS AND NEEDLES AND BURING PAIN SHE HAS HAD SHORTNESS OF BREATH SINCE THE IMPLANT BROKE AND IT SEEMS TO BE GETTING WORSE AT THIS POINT IN TIME SHE GUESSES SHED BE CONSIDERED DISABLED SHE HAS NOT WORKED SINCE 1988 HER HANDS CAN ONLY USE A PEN OR PENCIL FOR 10 MINUTES SHE HAS BLOOD PRESSURE PERIPHERAL NEUROPATHY ANXIETY OR DEPRESSION ORGANIZATIONAL DIFFICULTY LACK OF CONCENTRATION SHORT-TERM MEMORY LOSS MOOD SWINGS BALANCE DISTURBANCESVERTIGODIZZINESS RAPID DETERIORATION OF EYESIGHT OFTEN GASTRITIS CONNECTIVE TISSUE DISEASE  CHRONIC SWOLLEN LYMPH NODES UNDER ARMS FROZEN SHOULDER MUSCLE PAIN  BURNING UNEXPLAINED RASHES UNEXPLAINED SEVERE ITCHING SLEEP NON-RESTORATIVE SLEEP CHRONIC FATIGUE SYNDROME LONG-TERM EXTREME FATIGUE |HEYER-SCHULTE GEL-FILLED MAMMARY PROSTHESIS||11/17/1995|B|||Y||29070.0|*|FTR|1.0||MAMMARY PROSTHESIS|N||||MCGAW PARK|US|BAXTER V. MUELLER||IL|60085||||True
12579|20526368|D|1||101074 BILATERAL BREAST AUGMENTATION USING SILICONE GEL BREAST IMPLANTS SINCE THAT TIME RPTR HAS BEEN SUFFERING FROM MUSCULAR PAIN AND STIFFNESS IN HER NECK BACK AND SHOULDER SHE HAS BEEN DIAGNOSED WITH FIBROSITIS AN AUTOIMMUNE CONNECTIVE TISSUE DISEASE A PHYSICAL EXAM BY A PLASTIC SURGEON REVEALS CAPSULAR CONTRACTURES AS WELL AS CALCIFICATION OF BOTH CAPSULES IN THE BREASTS XEROMAMMOGRAM AND ULTRASOUND CONFIRM BILATERAL RUPTURES OF IMPLANTS HER INTERNIST STATES HER PAST MEDICAL HISTORY IS SIGNIFICANT FOR FIBROSITIS HYPOTHYROIDISM DEPRESSION ALLERGIC RHINITIS LEAKING BREAST IMPLANT HORMONE IMBALANCE ALOPECIA INFERTILITY AND MISCARRIAGE TEMPOROMANDIBULAR JOINT DYSFUNCTION OR MYOFASCIAL PAIN SYNDROME AND DERMATITIS HER SYMPTOMS ARE CONSISTENT WITH SILICONE ASSOCIATED ILLNESS|SILASTIC ROUND BREAST IMPLANT|590|04/05/1994|B|||Y||12579.0|*|FTR|1.0||nan|N|HH0243|||MIDLAND|US|DOW CORNING CORP.||MI|48686||||True
511|231|D|1||THIS PATIENT HAD PLACED IN JANUARY 1988 BILATERAL IMPLANTS  THE PATIENT DEVELOPED RHEUMATOID ARTHRITIS NOVEMBER 1988  THE PATIENT COMPLAINED OF PAIN BEHIND THE LEFT BREAST  A BILATERAL CAPSULECTOMY WITH THE REMOVAL OF THE IMPLANTS WAS PERFORMED  THE RIGHT CAPSULE WAS OPENED WITH SOME EXUDATE PRESENT  BOTH IMPLANTS WERE INTACT  THIS REPORT WAS SUBMITTED 31292 BUT I WAS UNABLE TO CONFIRM IT BEING SENTINVALID DATA - REGARDING SINGLE USE LABELING OF DEVICE  PATIENT MEDICAL STATUS PRIOR TO EVENT  SATISFACTORY CONDITION  THERE WAS NOT MULTIPLE PATIENT INVOLVEMENTINVALID DATA - ON DEVICE SERVICEMAINTENANCE  NO DATA - REGARDING DATE LAST SERVICED  SERVICE PROVIDED BY  INVALID DATA  INVALID DATA - SERVICE RECORDS AVAILABILITY  INVALID DATA - REGARDING WHETHER EVENT PRESENTS IMMINENT HAZARD  INVALID DATA - WHETHER DEVICE USED AS LABELEDINTENDED  DEVICE WAS EVALUATED AFTER THE EVENT  METHOD OF EVALUATION  VISUAL EXAMINATION OTHER  RESULTS OF EVALUATION  NONE OR UNKNOWN  CONCLUSION  NO DATA  CERTAINTY OF DEVICE AS CAUSE OF OR CONTRIBUTOR TO EVENT  INVALID DATA  CORRECTIVE ACTIONS  INVALID DATA  THE DEVICE WAS DESTROYEDDISPOSED OF|REPLICON|UNKNOWN|04/23/1992||||N||504.0|000|FTR|1.0||POLYURETHANE COVERED SILICONE GEL BREAST IMPLANTS|Y|UNKNOWN|||||SURGITEK|||||UNKNOWN|UNKNOWN|True
25698|15195|D|1||PT HAD MAMMOGRAM CONFIRM RUPTURED LEFT IMPLANT SILICONE AT THIS TIME PT DECIDED TO HAVE SILICONE IMPLANTS REMOVED  SALINE IMPLANTS IMPLANTED|MAMMARY IMPLANT|27-120261 RIGHT & LEFT|07/31/1995|V||6 YR|Y||26274.0|0HP|FWM|1.0||IMPLANT|Y|RIGHT DH3680,LEFT DI2415|700 WARD DR||SANTA BARBARA|US|MCGHAN MED CORP||CA|93111||STYLE 120||True
16279|16479544|D|1||RPTR HAD BILATERAL AUGMENTATION MAMMOPLASTY 1175 WITH 210 CC SILICONE FILLED IMPLANTS MAMMOGRAMS AND MRI ON 5494 CONFIRM BILATERAL RUPTURE HISTORY OF MANUAL CAPSULE RELEASES IN 1980 PT NEVER INFORMED OF ABNORMAL MAMMOGRAMS REPORTS NEVER CITED THIS FINDING BUT RUPTURES ARE CLEARLY EVIDENT ON 1ST MAMMOGRAM IN 1986|HEYER-SCHULTE SILICONE GEL-FILLED MAMMARY PROSTHESIS 210 CC||09/20/1994|*|||*||16212.0|*|FTR|1.0||SILICONE-FILLED BREAST IMPLANT|Y||||MCGAW PARK|US|V. MUELLER DIV. BAXTER HEALTHCARE CORP.||IL|60085||||True
8897|6778|D|1||THIS PATIENT HAD PLACE IN JANUARY 1988 BILATERAL BREAST IMPLANTS  THE PATIENT DEVELOPED RHEUMATOID ARTHRITIS NOVEMBER 1988 THE PATIENT COMPLAINED OF PAIN BEHIND THE LEFT BREAST  A BILATERAL CAPSULECTOMY WITH THE REMOVAL OF THE IMLANTS WAS PERFORMED  THE RIGHT CAPSULE WAS OPENED WITH SOME EXUDATE PRESENT  BOTH IMPLANTS WERE INTACT  THIS REPORT WAS SUBMITTED 31292 BUT I WAS UNABLE TO CONFIRM IT BEING SENT  THIS REPORT IS LATE BECAUSE THE ORGINAL REPORT WAS SENT TO THE FDAINVALID DATA - REGARDING SINGLE USE LABELING OF DEVICE  PATIENT MEDICAL STATUS PRIOR TO EVENT  SATISFACTORY CONDITION  THERE WAS NOT MULTIPLE PATIENT INVOLVEMENTINVALID DATA - ON DEVICE SERVICEMAINTENANCE  NO DATA - REGARDING DATE LAST SERVICED  SERVICE PROVIDED BY  INVALID DATA  INVALID DATA - SERVICE RECORDS AVAILABILITYINVALID DATA - REGARDING WHETHER EVENT PRESENTS IMMINENT HAZARD  INVALID DATA - WHETHER DEVICE USED AS LABELEDINTENDEDDEVICE WAS EVALUATED AFTER THE EVENT  METHOD OF EVALUATION  VISUAL EXAMINATION OTHER  RESULTS OF EVALUATION  INVALID DATA  CONCLUSION  INVALID DATA  CERTAINTY OF DEVICE AS CAUSE OF OR CONTRIBUTOR TO EVENT  INVALID DATA  CORRECTIVE ACTIONS  OTHER  THE DEVICE WAS DESTROYEDDISPOSED OF|REPLICON|UNKNOWN|07/22/1993||||N||8558.0|*|FTR|1.0||POLYURETHANE COVERED SILICONE GEL IMPLANTS|Y|UNKNOWN|||||SURGITEK|||||UNKNOWN|UNKNOWN|True
32942|15028047|D|1||THE PT IS A 46-YR-OLD WHITE FEMALE WHO IN 1978 HAD BILATERAL BREAST AUGMENTATION USING GEL FILLED IMPLANTS SHE DEVELOPED WEIGHT GAIN RASH ON FACE CHEEKS NOSE AND FOREHEAD AND ACNE ON THE FACE AND NECK AREA SHE HAS A LOSS OF SHORT-TERM MEMORY IN THE 1980S AND AT THE PRESENT TIME SHE HAS A TERMENDOUS AMOUNT OF NECK TIGHTNESS WITH HEADACHE AND PAIN ARTHRALGIAS IN THE HIP SHOULDERS AND ELBOW REGIONS AND MUSCLE SPASMS THE PT ALSO HAS FATIGUE AND DEPRESSION SHE HAS BREAST PAIN IN THE AXILLARY STERNAL AND NIPPLE AREA AND DEEP IN THE BREAST DRY EYES AND NUMBNESS AND TINGLING IN HER HANDS XEROMAMMOGRAM AND ULTRASOUND CONFIRM BILATERAL RUPTURED IMPLANTS WITH EXTRACAPSULAR RUPTURE ON THE LEFT THE PT ALSO HAS MELASMA IN THE CHEEKS AND SKIN AREA SHE HAS MULTIPLE TENDER POINTS IN THE CLASSICAL FIBROMYALGIA TRIGGER AREA BECAUSE OF BILATERAL RUPTURED IMPLANTS BREAST PAIN AND SYSTEMIC SYMPTOMS THAT MAY BE BOTH IMPLANTS TOTAL CAPSULECTOMY IS MEDICALLY NECESSARY BECAUSE OF RUPTURE|BREAST IMPLANT|UNKNOWN|04/26/1996|V||17 YR|N||34241.0|000|FTR|1.0||BREAST IMPLANT|Y|UNKNOWN|PO BOX 995||MIDLAND|US|DOW CORNING CORP.||MI|48611|0995|UNKNOWN||True
33073|18630|D|1||RPTR HAS BREAST IMPLANTS SINCE 1990 SINCE THAT TIME RPTR HAS HAD CONTINUED NECK AND SHOULDER PAIN HEADACHES AND RIGHT ARM PAIN HAS HAD PHYSICAL THERAPY AND HAS CONSULTED WITH AN INTERNIST A PSYCHIATRIST AND A NEUROLOGIST THESE PHYSICIANS COULD NOT CONFIRM IF SYMPTOMS WERE ASSOCIATED WITH HER IMPLANTS HAS NOT GONE BACK TO THE PLASTIC SURGEON WHO PUT IN IMPLANTS TO CONSULT WITH HIM HAS GATHERED INFO ABOUT SILICONE IMPLANTS AND FEELS THAT SHE IS STUCK BETWEEN A ROCK AND A HARD PLACE AND WOULD LIKE FURTHER INFO IF IT IS AVAILABLE|BREAST IMPLANT||05/20/1996|B|||*||34392.0|0LP|FTR|1.0||BREAST IMPLANT|N|||||*|UNKNOWN|||||||True
119469|17432291|D|1||RPTR HAS HAD A TOTAL OF 3 SURGERIES INCLUDING INITIAL IMPLANT SURGERY THE IMPLANTS WERE ORIGINALLY PLACED FOR COSMETIC REASONS FOLLOWING FIBROCYSTIC BREAST DISEASE THE RPTR HAS HAD A MEDICAL PROFESSIONAL CONFIRM THE PRESENCE OF SILICONE GEL OUTSIDE THE BREAST SCAR TISSUE CAPSULE IN HER UTERUS BRAIN AND SPINAL FLUID THE RPTR HAS BEEN DIAGNOSED WITH THE FOLLOWING AFTER IMPLANTATION CHRONIC INFECTIONS LOW BLOOD PRESSURE PERIPHERAL NEUROPATHY BRAIN LESIONS ANXIETY OR DEPRESSION LACK OF CONCENTRATION SHORT-TERM MEMORY LOSS PROCRASTINATION GETTING LOST OR CONFUSED BALANCE DISTURBANCESVERTIGODIZZINESS ATYPICAL M-S ORGANIC BRAIN SYNDROME PAIN OR BURNING SENSATION OF CHESTRIB CAGE INFLAMMATION ELEVATED CHOLESTEROL OR TRIGLYCERIDES RAPID DETERIORATION OF EYES THYROID PROBLEMS CHRONIC SWELLING OF HANDS OR FEET CHRONIC PAIN  DISCOLORATION RED OR BLUE OF HANDSFEET CHRONIC DIARRHEA OR CONSTIPATION ESOPHAGITIS DUODENITIS OR GASTRITIS 2 ESOPHAGEAL DILATIONS REFLUX BOWEL SPASMS HYSTERECTOMY A TYPICAL CHEST PAINIRREGULAR HEARTBEATS HYPERSENSITIVITY OR ALLERGIES TO CHEMICALS MOLDS DUST OR POLLEN CONNECTIVE TISSUE DISEASE ARTHRALGIA RHEUMATOID ARTHRITIS PERSISTENT JOINT STIFFNESS CHRONIC SWOLLEN LYMPH NODES  LYMPHADENOPATHY UNDER ARMS MUSCLE PAIN  BURNING FIBROMYALGIA MYOSITIS OR POLYMYOSITIS UNEXPLAINED RASHES SUN SENSITIVITY CHRONIC INSOMNIA VASCULITIS CHRONIC FATIGUE SYNDROME AND GRANULOMAS OR SILICONOMAS|MERVE/SURGITECK|LT 9330939,MEME RT 9230907|09/10/1997|M|||*||117129.0|0HP|FTR|1.0||BREAST IMPLANT|Y|*|2317 EATON LA.||RACINE|US|MEDICAL ENGINEERING CORP.||WI|53404||*|MP70280|True
90593|59987|D|1||UN UNSUBSTANTIATED REPORT WAS RECEIVED FROM PT WHICH DID INCLUDE LETTERS FROM PHYSICIANS THAT THAT THE PT HAD MULTIPLE SYSTEM COMPLAINTS THESE COMPLAINTS APPARENTLY INCLUDE PARATHESIAS NUMBNESS AND PERIORBITAL PAIN WITH NUMBNESS AND PAIN ON THE LEFT SIDE RUPTURE WAS SUSPECTED PRIOR TO REMOVAL AND PATHOLOGY REPORT APPEARS TO CONFIRM THE RUPTURE THE DEVICES WERE REMOVED IN 1996 APPROXIMATELY TEN YEARS AFTER IMPLANTATION|ROUND LOW PROFILE MAMMARY PROSTHESES|RLP-260|05/12/1997|V||*|N|R|89530.0|0HP|FTR|1.0||GEL FILLED MAMMARY PROSTHESES|Y||1160 MARK AVE.||CARPINTERIA|US|CUI||CA|93013||||True
144160|93570|D|1||THIS 41 YR OLD WOMAN HAD SILICONE IMPLANTS AT THE AGE 0F 22 SHE HAS CONTINUED TO SUFFER NUMEROUS PROBLEMS INCLUDING MUSCLE  JOINT PAIN BURNING IN CHEST AND INSIDE BODY ESP LEGS SHE HAS ULCERS THAT COME  GO ON LEGS WHICH ARE PAINFUL  TAKE ABOUT A MO TO HEAL CHRONIC HEADACHES FATIGUE BACK PAIN INSOMNIA MEMORY LOSS BLACK DISCHARGE FROM NIPPLES A POSITIVE ANA WDIAGNOSIS OF LUPUS HAS BEEN IN HOSP MANY TIMES WCHRONIC BLADDER  KIDNEY PROBLEMS SHE HAS SPURS IN HER FEET AND ROOTS OF TEETH ARE DISINTEGRATED WABSCESSES  HAS HAD UPPER TEETH EXTRACTED CHRONIC SINUS PROBLEM AND DEPRESSION HAD A HYSTERECTOMY WTUMOR REMOVED NO SEXUAL LIBIDO AND HAIR LOSS DIGESTIVE PROBLEMS ALLERGIES AND ASTHMA AN MRI IN 1994 SHOWED STRETCHED  TORN IMPLANTS CONTAINING MASSES PT HAS NO MONEY AND IS ON WELFARE THIS WOMAN NEEDS HELP IN HAVING EXPLANATION PT HAS MANY LAB-REPORTS BUT PROBLEMS TO CONTINUE GOING TO DRS TO TRY  CONFIRM THE ABOVE SYMPTOMS TO BE RELATED TO IMPLANTS THE WOMAN IS VERY ILL HAS NO MONEY NO ENERGY  NO ONE TO HELP SHE TELLS RPTR BAXTER HAS OFFERED PT 20000 WHICH SHE HAS REFUSED RPTR IS SENDING THIS REPORT AS REQUESTED BY THIS WOMAN|BAXTER|*|01/05/1998|*|||*||140586.0|0HP|FTR|1.0||SILICONE BREAST IMPLANTS|Y|*|1500 WAUKEGAN RD.||MCGAW PARK|US|ALLEGIANCE HEALTHCARE CORP.||IL|60085||*|*|True
201203|21607371|D|1||THIS 50 YEAR OLD FEMALE UNDERWENT A BILATERAL AUGMENTATION MAMMOPLASTY WITH SILICONE GEL BREAST IMPLANTS IN 1974 INFO REGARDING THE IMPLANTS IS NOT AVAILABLE TO THIS REPORTING FACILITY A MAMMOGRAM AND ULTRASOUND CONFIRM A RUPTURE OF THE LEFT IMPLANT GROSS EXAM THE LEFT IMPLANT IS MASSIVELY RUPTURED|*|UNK|12/07/1998|V||24 YR|N||195437.0|0LP|FTR|1.0||MAMMARY PROSTHESIS|Y|*|UNK||UNK|*|UNK|||||UNK|*|True
155834|7775238|N|1||DATE OF THIS REPORT 72399 EVAL SUMMARY BASED ON THE INFO RECEIVED AND THE RESULTS OF THE LIMITED LABORATORY EVAL PE WAS UNABLE TO CONFIRM THE REPORTED RUPTURE OF THE PTS PROSTHESES BECAUSE OF THE CLASS ACTION AND CONCERNS OF POSSIBLE SPOLIATION OF EVIDENCE MENTOR IS PROHIBITED FROM CONDUCTING PHYSICAL EVAL OF THESE COVERED DEVICES WITHOUT THE BENEFIT OF ADDITIONAL EVAL TO INCLUDE LEAK TESTING AND MICROSCOPIC EXAMINATION PE WAS UNABLE TO IDENTIFY ANY LEAKAGE SITES WHICH MAY HAVE CONTRIBUTED TO THE REPORTED RUPTURE OF THE DEVICES|SILTEX LOW BLEED GEL|354-2757 354-2757|03/10/1998|V|07/12/1999||R|Y|151795.0|0HP|FTR|1.0||MAMMARY PROSTHESIS|Y|60450R 52096|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR||TX|75038||||True
141992|87018|D|1||PT ALLEGES HER RIGHT IMPLANT IS RUPTURED OPERATIVE REPORT STATES THE ULTRASOUND EXAMINATION APPEARED TO CONFIRM THE APPEARANCE OF A RUPTURED RIGHT IMPLANT HOWEVER POSTOPERATIVE DIAGNOSES STATES INTACT RIGHT BREAST SILICONE PROSTHESIS WITH CAPSULAR CONTRACTURE AND HERNIATION OF IMPLANT THROUGH CAPSULE AND INTACT LEFT BREAST SILICONE PROSTHESIS|SILASTIC II MAMMARY IMPLANT, H.P. LPR|P0140245|01/06/1998|*|||N|R|138525.0||FTR|1.0||MAMMARY IMPLANT, GEL-FILLED|Y|UNK|2200 WEST SALZBURG ROAD||AUBURN|US|DOW CORNING CORPORATION||MI|48611||||True
218972|18950873|D|1||ON 13095 RUPTURE OF RIGHT BREAST IMPLANT ON 3895 BOTH MAMMARY PROSTHESIS REPLACED MFR WRITES THANK YOU FOR BRINGING TO OUR ATTENTION THE RECENT INCIDENT AT YOUR MEDICAL CTR INVOVLING OUR PRODUCT SMOOTH SALINE ON 2695 PRODUCT EVALUATION RECEIVED A TELEPHONE CALL REPORTING THE PTS INFO THE COMPLAINT WAS DEFLATION OF THE RIGHT DEVICE AND AUTO-IMMUNE TYPE SYMPTOMS ON 4291 DR IMPLANTED A SMOOTH SALINE-FILLED MAMMARY PROSTHESIS CATALOG NO 350-1650 LOT NO 25760 SUBMUSCULARLY AS PART OF A BILATERAL AUGMENTATION AT IMPLANTATION THE DEVICE WAS FILLED WITH 425 CC OF SALINE RECOMMENDED FILL VOLUME IS 325 + 50 CC ON 2295 THE PT REPORTEDLY EXPERIENCED A DEFLATION OF THE RIGHT DEVICE ON 22095 BOTH DEVICES WERE EXPLANTED ON 102795 THE PT REPORTED THAT SHE WAS EXPERIENCING NUMEROUS HEALTH PROBLEMS INCLUDING BUT NOT LIMITED TO OSTEOARTHRITIS FYBROMYALGIA RAYNAUDS PNEUMONION SCLERODERMA AND DEGENERATIVE DISC DISEASE THE PT REPORTEDLY HAS NOT SEEN HER DR SINCE HER SUTURES WERE REMOVED ONE SMOOTH SALINE-FILLED MAMMARY PROSTHESIS WITH DIAPHRAGM VALVE CATALOG NUMBER 350-1650 LOT NUMBER 25760 WAS RETURNED TO MENTOR HS FOR PRODUCT EVALUATION AS RECEIVED THE DEVICE APPEARED TO BE INTACT WITH THE FILL TUBE INSERTED INTO THE DIAPHRAGM VALVE THERE WAS A TRACE AMOUNT OF UNK CLEAR FLUID INSIDE THE DEVICE AN UNK WHITE SUBSTANCE WAS ON THE ANTERIOR SIDE OF THE DEVICE ON THE POSTERIOR SIDE OF THE DEVICE WAS AN UNK BROWN SUBSTANCE AN UNK GREEN SUBSTANCE WAS ON THE DIAPHRAGM VALVE AND THE FILL TUBE NO OTHER ANOMALIES WERE OBSERVED BECAUSE THE PT IS CONSIDERED PART OF THE CLASS ACTION PRODUCT EVALUATION WAS PRECLUDED FROM PERFORMING A LEAK TESTING OR PERFORMING A MICROSCOPIC EXAMINATION ON THE DEVICE BASED ON THE LIMITED PRODUCT EVALUATION THE DEVICE APPEARED INTACT PRODUCT EVALUATION WAS UNABLE TO CONFIRM THE REPORTED DEFLATION OF THE RIGHT DEVICE WITHOUT THE BENEFIT OF FURTHER INVESTIGATION TO INCLUDE LEAK TESTING AND A MICROSCOPIC EXAMINATION OF THE DEVICE PRODUCT EVALUATION WAS UNABLE TO IDENTIFY ANY LEAKAGE SITES WHICH MAY HAVE CONTRIBUTED TO THE REPORTED DEFLATION OF THE DEVICE BECAUSE OF THE CLASS ACTION AND CONCERNS OF POSSIBLE SPOLIATION OF EVIDENCE MENTOR HS IS PROHIBITED FROM CONDUCTING PHYSICIAL EVALUATION OF THE COVERED DEVICE WITHOUT THE BENEFIT OF ADDL INVESTIGATION NO FURTHER CONCLUSION CAN BE MADE AT THIS TIME BASED ON THE INFO RECEIVED AND WITHOUT THE PTS MEDICAL RECORDS PRODUCT EVALUATION WAS UNABLE TO VERIFY THE REPORTED AUTO-IMMUNE TYPE SYMPTOMS THE DEVICE HISTORY RECORD FOR THIS PRODUCT WAS SEARCHED AND IT WAS DETERMINED THAT AT THE TIME OF MFR THE PRODUCT MET ALL IN HOUSE SPECS|MENTOR|350-1650|04/13/1999|V|03/08/1995||R||212362.0|0HP|FWM|1.0||MAMMARY PROSTHESIS|Y|25760|3041 SKYWAY CIRCLE NORTH||IRVING|US|MENTOR TEXAS, INC.||TX|75038||*|MENTOR REF # 950505|True
289743|166075|D|1||"SP B TRANSAX SUBGL GELS  TYPE  SIZE-NO RECORDS FOR AUGMENTATION PT CO SET DECREASED SIZE NO TRAUMA AND SOME RECENT L PAIN RADIATING INTO ARM ARTHRALGIASMYALGIAS PARESTHESIASDYSESTHESIAS SPASMS SWELLING FATIGUE SLEEP DISTURB ADENOPATHY INCREASED WBC HOT FLASHESFEVERS NIGHT SWEATS HEADACHES VISUAL DISTURB DIZZINESS MEMORY LOSS DRY MUCUS MEMBRANES RASHES CHOKING EPISODES CHOLESTEROL AND GIGU PROBS
289751|187615|D|1||CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE PULSE GENERATOR IPG WAS EXPLANTED DUE TO AN ELECTIVE REPLACEMENT INDICATOR
289765|16027752|D|1||EVENT DESCRIPTION GUIDANTCPI RECEIVED INFORMATION THAT THIS IMPLANTABLE PULSE GENERATOR IPG COULD NOT BE INTERROGATED  THE PHYSICIAN ELECTED TO EXPLANT THE IPG AND IMPLANT A NEW ONE
289767|15263050|D|1||EVENT DESCRIPTION GUIDANTCPI RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS IPG IMPLANTABLE PULSE GENERATOR HAD FAINTED AND HAD SOME ANGINA WHEN EXERCISING
289779|187764|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD DEVICES TACHYCARDIA MODE WAS PROGRAMMED OFF AND BRADYCARDIA PACING WAS CHANGED FROM DDD MODE TO VVI MODE AT 75V10MS
289786|17024716|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT DURING ATTEMPTED IMPLANT TWO SEPARATE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ICD EXHIBITED NON CONVERSION AND DISPLAYED SHORTED LEAD INDICATORS ASSOCIATED WITH THIS TRANSVENOUS DEFIBRILLATION LEAD
289651|21612485|D|1||IT WAS REPORTED THAT DURING A PTCA PROCEDURE THE SHAFT OF THE CATHETER BROKE DURING WITHDRAWAL OUTSIDE OF THE PT NO PT INJURIES OR COMPLICATIONS OCCURRED
289667|21712852|D|1||PT PRESENTED WITH BAKER CLASS IV CAPSULAR CONTRACTURES BILATERAL PT HAS BREAST PAIN ON 61400 CAPSULOTOMIES WERE PERFORMED WITH GEL IMPLANTS REMOVED THE RIGHT IMPLANT WAS INTACT THE LEFT IMPLANT WAS RUPTURED THE IMPLANTS WERE SENT TO THE LAB AND SALINE IMPLANTS WERE REINSERTED MCGHAN STYLE 68 210CC BILATERALLY
289795|17247507|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS TRANSVENOUS DEFIBRILLATION LEAD EXHIBITED IMPEDANCE  2000 OHMS AT A ROUTINE FOLLOW-UP EGMS AND R-WAVE WERE NORMAL IT WAS DECIDED TO IMPLANT A NEW SYSTEM THE LEAD WAS CAPPED AND NO DEFECTS WERE NOTED SHOCK IMPEDANCE OF TGE KEAD WAS NORMAL
289807|166217|D|1||EVENT DESCRIPTION GUIDANT RECEIVED INFORMATION THAT THIS PATIENT WITH A TRANSVENOUS DEFIBRILLATION LEAD HAD RECEIVED INNAPROPRIATE SHOCKS  WHEN THE LEAD WAS REMOVED FROM SERVICE THEY NOTED THE LEAD WAS FRACTURED
289815|183205|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD FAILED TO CONVERT THE PATIENT FOLLOWING AN INDUCTION  AN X-RAY OF THE IMPLANT SITE NOTED THE LEAD WAS TWISTED BEHIND THE ICD CASE AND THE INSULATION APPEARED TO BE ABRADED THROUGH
289829|187772|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE PULSE GENERATOR IPG WAS EXHIBITING VENTRICULAR OVERSENSING IN UNIPOLAR MODE  THE VENTRICULAR SENSITIVITY OF THE DEVICE WAS 05MV
289830|148869|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD DEVICE EXHIBITED A POSSIBLE DEVICE MALFUNCTION MESSAGE TECHNICAL SERVICES RECOMMENDED IMMEDIATE DEVICE REPLACEMENT
289840|187774|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD DEVICE WAS EXHIBITING OUT OF RANGE INDICATORS NO TONES WERE GENERATED WITH MAGNET APPLICATION
289843|166388|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THE PHYSICIAN BELIEVED THIS MYOCARDIAL LEAD WAS FRACTURED LEADING TO INAPPROPRIATE SHOCKS THE ENTIRE SYSTEM WAS REPLACED THE DAY AFTER IMPLANT THE PATIENTS NEW TRANSVENOUS DEFIBRILLATION LEAD EXHIBITED OVERSENSING WHICH WAS NOT RESOLVED BY REPROGRAMMING OR REPOSITIONING  THE LEAD WAS EXPLANTED AND REPLACED WITH A TINED LEAD
289881|16482321|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD WAS EMITTING BEEP TONES AND WAS FOUND TO BE IN FALLBACK MODE  THE ICD WAS EXPLANTED AND REPLACED
289886|187938|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT INSULATION ON BOTH THE RATE SENSING AND SHOCKING LEGS OF THIS TRANSVENOUS DEFIBRILLATION LEAD WAS FRACTURED NEAR THE SUBCLAVIAN TIEDOWN RESULTING IN AN OPEN AND POSSIBLY SHORTED LEAD CONDITION THE DAMAGE WAS DUE TO PATIENT MANIPULATION OF THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD IN THE POCKET BECAUSE OF CONCERN ABOUT POSSIBLE DAMAGE TO THE DEVICE BOTH THE LEAD AND DEVICE WERE EXPLANTED AND REPLACED
289890|166556|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD DEVICE EXHIBITED A FAULT CODE FOLLOWING MANUAL CAPACITOR REFORMATION PRE-IMPLANT TESTING
289909|22167304|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE PULSE GENERATOR IPG EXHIBITED AN INTERMITTENT LOSS OF CAPTURE UPON RE-INTERROGATION THE ISSUE COULD NOT BE RECREATED THE PHYSICIAN ELECTED TO LEAVE THE SYSTEM IMPLANTED WITHOUT REPROGRAMMING
289910|17248427|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD WAS OVERSENSING WHILE THE PATIENT WAS STRAINING ON THE COMMODE  NOISE WAS ALSO NOTED WHICH RESULTED IN THE INHIBITION OF PACING IN THIS PACER DEPENDENT PATIENT
289912|180991|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD WOULD NOT COMMUNICATE WITH A PROGRAMMER OR RESPOND TO MAGNET APPLICATION
289916|180992|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD EXPIRED  A REVIEW OF THERAPY HISTORY NOTED THAT THE ICD EXHIBITED A LESS THAN 10 OHM SHOCKING IMPEDANCE MEASUREMENT DURING A DELIVERED SHOCK  THE ICD DELIVERED FOUR SUBSEQUENT SHOCKS WITH SHOCKING IMPEDANCE MEASUREMENTS OF 151 OHMS
289923|17823588|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD DEVICE WAS EXHIBITING PREMATURE BATTERY DEPLETION AND MODEL125 WAS DEMONSTRATING HIGH PACING THRESHOLDS
289941|166710|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT INSULATION DAMAGE WAS NOTED TO THE RATE SENSE PORTION OF THIS ENDOTAK C LEAD THE DAMAGE WAS REPAIRED AND THE LEAD WAS ATTACHED TO THIS VENTAK PRXIII IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD WHICH EXHIBITED A SHORTED SHOCKING LEAD MESSAGE AFTER A SHOCK WAS DELIVERED UPON EXAMINING THE LEAD AGAIN DAMAGE WAS NOTED BETWEEN THE YOLK AND THE TERMINAL PIN THIS DAMAGE WAS REPAIRED WITH A SLEEVE BUT ANOTHER SHOCKING ATTEMPT NOW REVEALED AN IMPEDANCE OF GREATER THAN 3000 OHMS FRACTURE OF BOTH THE RATE SENSE AND SHOCKING PORTION OF THE LEAD WAS NOTED AT THE END OF THE SLEEVE THE FRACTURE WAS THOUGHT TO BE INDUCED DURING THE PROCEDURE BY STRESS AT THE END OF THE SLEEVE
289961|14871629|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD HAD RECORDED EPISODES THAT INDICATED POSSIBLE OVERSENSING OF ATRIAL FIBRILLATION  THE DEVICE ALSO PROVIDED SHOCKS INTO A NORMAL VENTRICULAR RHYTHM DURING PERIODS OF ATRIAL ARRYTHMIA AND ISOMETRIC EXERCISES
289964|18161654|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS TRANSVENOUS DEFIBRILLATION LEAD EXHIBITED A SHORTED LEAD CONDITION DURING A REPLACEMENT PROCEDURE
289971|19960664|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE PULSE GENERATOR IPG WAS REMOVED BECAUSE IT EXHIBITED PREMATURE BATTERY DEPLETION
289973|19173406|D|1||EVENT DESCRIPTION GUIDANTCRM RECEIVED INFORMATION THAT DUE TO INSULATION DAMAGE OF THE IS-1 RATE SENSE TERMINAL THE PATIENTS DEVICE WAS OVERSENSING  THE IS-1 TERMINAL PIN WAS CAPPED AND REINSULATED  THE HIGH VOLTAGE PORTION REMAINS ACTIVE AND A NEW RATE SENSING LEAD WAS ADDED TO THE SYSTEM
289977|20433907|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE PULSE GENERATOR IPG EXHIBITED A GAS GAUGE OF 25 DURING A FOLLOW-UP INTERROGATION THE DEVICES OUTPUT WAS REPROGRAMMED AND AT A SUBSEQUENT FOLLOW-UP THE GAS GAUGE MEASURED 50 NO FURTHER PROGRAMMING CHANGES WERE MADE AND THE IPG LATER EXHIBITED A GAS GAUGE MEASUREMENT OF 100 THE DEVICE WAS LATER REMOVED DUE TO PREMATURE BATTERY DEPLETION
289987|15037447|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE PULSE GENERATOR IPG REPORTED FARFIELD SENSING  THE DEVICE REMAINS IMPLANTED  ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION HAVE BEEN UNSUCCESSFUL
290002|149410|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS PACING LEAD EXHIBITED LOSS OF CAPTURE IN BIPOLAR MODE THE LEAD FUNCTIONED NORMALLY IN UNIPOLAR THE PHYSICIAN SUSPECTED LEAD FRACTURE AND REPLACED THE LEAD
290004|181179|D|1||EVENT DESCRIPTION GUIDANTCPI RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTABLE PULSE GENERATOR IPG WAS IN AN AUTO ACCIDENT  AFTER THE ACCIDENT THE IPG HAD VENTRICULAR OVERSENSING  DURING THE INVASIVE PROCEDURE BOTH THE IPG AND VENTRICULAR LEAD WERE EXPLANTED AND REPLACED  THE IPG WAS RETURNED FOR ANALYSIS
290005|20161940|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THE PHYSICIAN WAS UNABLE TO ESTABLISH TELEMETRY WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD  THE ICD WAS REMOVED AND REPLACED
290010|181180|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD DELIVERED INAPPROPRIATE THERAPY AND THAT THE LOWER RATE LIMIT WAS BELOW THE PROGRAMMED LOWER RATE LIMIT  AN EVALUATION OF STORED ELECTROGRAMS REVEALED THE PRESENCE OF EXTERNAL NOISE AND INHIBITION OF PACING
290016|188277|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD HAD RECORDED AN EPISODE THAT INDICATED POSSIBLE OVERSENSING  AS DESIGNED THE DEVICE DID NOT PROVIDE BRADY PACING DURING THE LAST FEW SECONDS OF THE EPISODE
290017|149553|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD DEVICE DID NOT GENERATE TONES DURING MAGNET APPLICATION AND COULD NOT BE INTERROGATED TECHNICAL SERVICES RECOMMENDED IMMEDIATE DEVICE REPLACEMENT AND VIGOROUS LEAD ASSESSMENT
290030|21379497|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT WITHIN 1 WEEK AFTER IMPLANT THIS VENTRICLAR PACING LEAD EXHIBITED INTERMITTENT LOSS OF CAPTURE A DECREASE IN R WAVE AMPLITUDE AND SOME INCREASE IN IMPEDANCE CHEST X-RAY COULD NOT CONFIRM DISLODGEMENT BUT THE LEAD APPEARED POSSIBLY TOO SHORT TO PROVIDE FLEXIBILITY ON JAN 5TH THE DEVICE WAS REPROGRAMMED TO AAI THREE WEEKS LATER THE PHYSICIAN OPTED TO REPLACE RATHER THAN REPOSITION THE LEAD
290033|20682537|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD SYSTEM EXHIBITED A SHORTED LEAD FAULT CODE WHEN INTERROGATED FOLLOWING A SHOCK REPORTED BY THE PATIENT
290044|16292317|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS INTERMEDICS THINLINE LEAD BECAME DISLODGED LEAD WAS REPLACED
290052|188450|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD WAS NOT IMPLANTED DUE TO A LOW MONITORING VOLTAGE
290056|149557|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD WAS EXPLANTED DUE TO ERI  THERE WERE NO ALLEGATIONS AGAINST THE PERFORMANCE OF THE DEVICE
290063|167043|D|1||EVENT DESCRIPTION GUIDANT RECEIVED INFORMATION THAT DURING AN EXPLANT PROCEDURE TO REMOVED AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD FOR ELECTIVE REPLACEMENT THERE WAS EVIDENCE OF A LEAD FRACTURE THE DEVICE CHARGED THERE WAS ERONIOUS SENSING  THE EPISODE DETAIL SHOWED SHORT AND FAST DETAILS THE PATIENTS ENTIRE CHRONIC LEAD SYSTEM WAS REMOVED AND REPLACED WITH A NEW SYSTEM
290068|188453|D|1||EVENT DESCRIPTION GUIDANTCPI RECEIVED INFORMATION THAT THIS IPG IMPLANTABLE PULSE GENERATOR EXHIBITED A BATTERY STATUS INDICATOR OF ERI ELECTIVE REPLACEMENT INDICATOR  IT HAS BEEN PROGRAMMED AT NOMINAL OUTPUTS AND HAD BEEN IMPLANTED FOR APPROXIMATELY 3 MONTHS EARLY BATTERY DEPLETION THERE WAS NO MAGNET RESPONSE AND THE IPG COULD NOT BE INTERROGATED THE IPG WAS EXPLANTED AND REPLACED WITH ANOTHER CPI IPG  IT WAS RETURNED TO ST PAUL FOR ANALYSIS
290083|16270099|D|1||DIFFICULT DEFLATION DUE TO ENCAPSULATION
290089|188455|D|1||IT WAS REPORTED THAT 1 DEVICE WAS USED DURING AN UNKNOWN PROEDURE IT WAS REPORTED BY THE AFFILIATE THAT THE MCM30 CLIPS WOULD NOT DELIVER ANOTHER INSTRUMENT WAS USED TO COMPLETE THE CASE THERE WAS NO CONSEQUENCE TO THE PT
290091|181335|D|1||DURING A PTA PROCEDURE IN THE SUPERFICIAL FEMORAL ARTERY THE BALLOON BURST AT 9 ATMOSPHERES
289969|15678197|D|1||EVENT DESCRIPTION CPI RECEIVED INFORMATION THAT FOLLOWING AN MRI PROCEDURE THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ICD COULD NOT BE INTERROGATED AND THE TACHY MODE COULD NOT BE CHANGED  THE ICD WAS REMOVED AND REPLACED CPI RECEIVED THIS ICD BACK FOR ANALYSIS IN AUGUST 1999
290113|149707|D|1||IT WAS REPORTED THE CUSTOMER WAS REQUESTING ASSISTANCE ON TROUBLESHOOTING A HANDPIECE THE HANDPIECE WAS FOUND TO BE BAD SOLID TONES ON BLADE AND 2 TEST TIPS THE CUSTOMER IS ALSO REQUESTING A SERVICE MANUAL PN 44913 QUANTITY 1
290154|167193|D|1||ON THE WAY OF TURNING WING NUT IT CAME TO BE STIFF THEN THE SHAFT COULD NOT BE ADVANCED FULLY ENOUGH USED ANOTHER DEVICE NO PT INJURY
290161|18161655|D|1||SP B SUBMUSC TRANSAX DC SALINES FOR AUGMENTATION PT CO R BEING SMALLER X A FEW YRS BUT DENIES DECREASED SIZE OR HO TRAUMA THE L ENCAPSULATED 1 YR AFTER SX HAD MOD LOCAL PAIN L GREATER THAN R MAIN CONCERN IS SYSTEMIC PROBS WHICH HAVE DEVELOPED IN LAST 4 YRS THESE INCLUDE ARTHRALGIAS UPPER GREATER THAN LOWER WITH + AM STIFFNESSMYALGIAS PARESTHESIASDYSESTHESIAS SPASMS FATIGUE SLEEP DISTURB SORE THROATS FREQUENT SINUSITIS HEADACHES VISUAL CHANGES DIZZINESS MEMORY LOSS HAIR LOSS ITCHING PHOTOPHOBIA AND MISCARRIAGE PT IS OTHERWISE HEALTHY"|SILICONE GEL BREAST IMPLANTS|UNK|07/25/2000|V|||*||280399.0|*|FTR|1.0||UNK|Y|UNK|*||*|*|DOW CORNING|||||UNK|UNK|True
289500|20989384|D|1||SP B SUBMUSC SALINE IMPLANTS FOR CORRECTION OF INVOLUTIONAL PTOSIS NO RECORDS TO CONFIRM CO L BEING SMALLER FROM THE BEGINNING DENIES DECREASED SIZE BUT THEY ARE MORE DROOPY DENIES CHANGED TEXTURE OR HO TRAUMA BUT ABOUT 14 MOS AGO DEVELOPED SEVERE PAIN L GREATER THAN R INTERMITTENT IT IS NOW RESOLVED X 2-4 MOS  ETIOLOGY PT HAS SOME MILD SYSTEMIC SXS FOR YRS INCLUDING ARTHRALGIAS + AM STIFFNESSMYALGIAS PARESTHESIASDYSESTHESIAS FATIGUE SPASMS SLEEP DISTURB HOT FLASHESSWEATS HEADACHES DIZZINESS MEMORY PROBS SOB WGT FLUCTUATIONS NAUSEA AND EASY BRUISING PT IS OTHERWISE HEALTHY|MENTOR|350-1860M|07/25/2000|V|||N||280161.0|*|FTR|1.0||GEL BREAST IMPLANTS|Y|8018|*||*|*|MENTOR|||||||True
341676|15677094|D|1||PT RECEIVED DOUBLE SALINE-FILLED BREAST IMPLANTS IN 2000 ONE DAY IN 2001 THE PT DISCOVERED THAT THE PTS RIGHT BREAST HAD DEFLATED IN SIZE THE NEXT DAY THE DR DETERMINED THAT THE IMPLANT WAS LEAKING THE LEAKING IMPLANT WAS THEN REPLACED 9 DAYS LATER BY THE SAME DR WITH THE SAME PIP TYPE IMPLANT THE COMPLAINANT STATED THAT A JACKSONPRATT DRAIN WAS PLACED IN THE RIGHT BREAST TO RID IT OF EXCESS SALINE THE COMPLAINANT STATED THAT THE JACKSONPRATT DRAIN CREATED A SCAR AFTER THE PT RECEIVED THE REPLACEMENT IMPLANT THE PT NOTICED A DIFFERENCE IN SIZE BETWEEN THE RIGHT AND LEFT BREAST TO CONFIRM THIS PT VISITED A SECOND DR A MEASUREMENT WAS TAKEN AND THERE IS A 2 MM DIFFERENCE AFTER IMPLANT DONE IN 2000 PT FOUND OUT THAT THE PIP TYPE IMPLANTS HAD BEEN DISAPPROVED FOR USE IN A PHONE CONVERSATION WITH STAFF AT DRS OFFICE AND ALSO CONFIRMED BY 2ND DR AND ALSO IN THE FDA WEB SITE ACCORDING TO THE COMPLAINANT THE COMPLAINANT HAD SPOKEN TO THE AGENCY CONCERNING THE RECALLED IMPLANT|POLY IMPLANT PROSTHESIS|NI|06/21/2001|V|||*||331012.0|*|FWM|1.0||BREAST IMPLANT|Y|NI|9831 E EVERGREEN ST||MIAMI|US|POLY IMPLANT PROSTHESIS||FL|33157||NI|NI|True
375912|269528|D|1||ADDL INFO RECD FROM MFR 51002 MAKING AN INFORMED DECISION INDICATES THAT IMPLANT DEFLATION IS KNOWN COMPLICATION FOLLOWING BREAST IMPLANT SURGERY CAUSES OF DEFLATION INCLUDE DAMAGE BY SURGICAL INSTRUMENTS DURING SURGERY OVERFILLING OR UNDERFILLING OF THE IMPLANT WITH SALINE SOLUTION CAPSULAR CONTRACTURE CLOSED CAPSULOTOMY STRESSES SUCH AS TRAUMA OR INTENSE PHYSICAL MANIPULATION EXCESSIVE MANIPULATION EXCESSIVE COMPRESSION DURING MAMMOGRAPHIC IMAGING UMBILICAL INCISION PLACEMENT AND UNKUNEXPLAINED REASONS IT SHOULD BE UNDERSTOOD THAT BREAST IMPLANTS MAY WEAR OUT OVER TIME AND DEFLATERUPTURE THE DEVICE ASSOCIATED WITH THIS EVENT HAS NOT BEEN RETURNED FOR EVALUATION THEREFORE MCGHAN MEDICAL CANNOT PROVIDE A PROBABLE CAUSE TO THE REPORTED EVENT NOR CONFIRM THE COMMENT THAT THE IMPLANT WAS FLAWED WHEN INSERTED|MCGHAN MEDICAL CORP|27-363231|01/24/2002|V|||*||365002.0|0LP|FWM|1.0||SALINE FILLED BREAST IMPLANT|Y|LK6327|700 WARD DRIVE||SANTA BARBARA|US|MCGHAN MEDICAL CORP||CA|93111|2936|UNK|BREAST IMPLANT|True
438566|307113|D|1||BILATERAL RUPTURED BREAST IMPLANTS THOUGHT TO BE DOW CORNING BUT CANNOT CONFIRM SURGICALLY REMOVED|DOW CORNING|UNK|01/20/2003|V||*|Y||427486.0|0LP|FTR|1.0||BREAST IMPLANT|Y|UNK|*||*|*|*|||||UNK|UNK|True
552843|313502|D|1||ADDL INFO RECD FROM RPTR 92804 THIS REPORT AMENDS ORIGINAL MEDWATCH REPORT PT MEDICAL RECORDS CONFIRM THAT PT NEVER HAD REPLACEMENT IMPLANTS|MENTOR ACCORDING TO LABELS AFFIXED TO RECORD|UNK|09/07/2004|V|||N||542391.0|0HP|FTR|1.0||BILATERAL SILICONE GEL BREAST IMPLANTS|Y|UNK|UNK|UNK|UNK|*|UNK|||||UNK|UNK|True
552843|20510399|D|1||PT MEDICAL RECORDS CONFIRM THAT PT NEVER HAD REPLACEMENT IMPLANTS PT DEVELOPED CAPSULAR CONTRACTURES FROM THE 1986 MAMMARY PROSTHESES AND HAD TO UNDERGO A REVISION BY SAME PHYSICIAN IN 1997 IMPLANTS REMAIN IN SUBGLANDULAR POCKETS AND OVER SEVERAL YEARS BECAME ENCAPSULATED PT DEVELOPED MEDICAL PROBLEMS AND SYMPTOMS ASSOCIATED WITH SILICONE GEL IMPLANTS SIXTEEN YEARS LATER BILATERAL TOTAL ABLATIVE CAPSULECTOMIES WERE PERFORMED TO REMOVE IMPLANTS WHICH WERE GROSSLY RUPTURED CAPSULES HAD HARDENED AND CALCIFIED RESULTING IN THINNING OF OVERLYING BREAST TISSUE BREAST RECONSTRUCTION SECONDARY TO PROBLEMS WITH SILICONE IMPLANTS WAS DONE THE REMOVED IMPLANTS WERE IDENTIFIED BY DIRECT INSPECTION BY THE PATHOLOGIST AS HAVING EMBOSSED CONCENTRIC RINGS SUSPECT MEDICAL DEVICE INFO WAS INCORRECTLY STATED AS MENTOR IMPLANTS HAVE ATTRIBUTES OF AMERICAN HEYER-SCHULTE IMPLANTS AND NOT MENTOR THE ISSUE ARISES REGARDING THE AUTHENTICITY OF PRODUCT IDENTIFICATION LABELS PROVIDED AS PART OF PTS RECORDS IMPLANTS SHIPPED DIRECTLY FROM HOSPITAL|MENTOR ACCORDING TO LABELS AFFIXED TO RECORD|UNK|09/07/2004|V|||N||542391.0|0HP|FTR|1.0||BILATERAL SILICONE GEL BREAST IMPLANTS|Y|UNK|UNK|UNK|UNK|*|UNK|||||UNK|UNK|True
520127|354119|D|1||PT HAD PUT IN SALINE IMPLANTS AND THE IMPLANT HAD RUPTURED A LITTLE AT A TIME THEN ALL AT ONCE LEFT IMPLANT JUST DEFLATED DURING THIS TIME PT WAS SEENING A DERMATOLOGIST BECAUSE PT HAD AN ITCHING PROBLEM PT THOUGHT THEY WERE ALLERGIC AND SOMETHING WAS CAUSING MAYBE DUST OR SOME ELEMENT PT HAD AT HOME BUT NOTHING WOULD MAKE SENSE THEN PT STARTED LOSING THEIR MEMORY FROM TIME TO TIME PT WOULD HAVE A LOT OF DISCHARGE FROM THEIR EAR AND PT WAS LOSING THEIR HAIR PT HAD DRY MOUTH AND PT WAS ICHING MORE FREQUENTLY SOON PT WAS SO MISERABLE PT COULDNT HAVE A GOOD NIGHTS SLEEP WITHOUT ABOUT 4 BENADRYL TABS IT STARTED TO SHOW THAT PT WAS LOSING THEIR LEFT BREAST DURING THIS TIME PT WENT INTO EMERGENCY WITH PAIN AND BURNING SENSATION ALL OVER THEIR BODY PT FELT AS IF THEY WERE BURNING FROM THE INSIDE OUT AND IT WOULD SCAB UP AS IF PT DID BURN FORM THE INSIDE OUT BURNING WITH PINS AND NEEDLES FEELING AND PT WOULD RASH UP WITH WHELTS ALL OVER BUT MOSTLY LEGS FACE AND BACK OF KNEES WHERE JOINTS WERE AND STOMACH AND BACK PT WAS SO MISERABLE PT WAS CRYING CONSTANTLY PRAYING TO GOD TO JUST KILL THEM PT JUST WANTED TO GET IT OVER WITH AND DIE THEN IN FEBURAY THEIR BREAST HAD TOTALLY DEFLATED AND PT KNEW THAT IT WAS SALT COMING THROUGH THEIR PORES THAT WAS DOING THIS TO THEM IT MAKES SO MUCH SENSE PTS DR WONT CONFIRM BUT CAN YOU BLAME HIM IT IS HIS LIFE CAREER AND HIS MONEY SOON PT HAD BURN MARKS ON THEIR FACE AS WELL MAYBE WORSE ON THEIR BACK AND CHEST PT ITCHED CONSTANTLY AND WAS IN EXCRUTIATING PAIN 247 PT WOULDNT WISH THIS ON ANYONE ALL THE HOSP KNEW TO DO IS TO GIVE THEM BENADRYL SHOTAND OR STERIODS WHICH MADE THEM UNCOMFORTABLE TO WHERE PT COULD NOT FUNCTION OR WALK OR SIT DOWN DUE TO EXCESSIVE WATER GAIN PT FELT LIKE A PILSBURY DOUGH PERSON|MC GHAN|*|03/25/2004|*|||*||509220.0|*|FWM|1.0||SALINE BREAST IMPLANT|Y|*|*||*|*|*|||||*|*|True
742613|17687147|N|1||NO PRODUCT RETURNED AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATION NO CONCLUSION CAN BE DRAWN|*||06/13/2006|*||||Y|706481.0||FWM|1.0||nan|Y||||||nan|||||||True
740285|7848485|N|1||VISUAL INSPECTION NO PRODUCT WAS RETURNED PRODUCT INSPECTION AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATIONS CONCLUSION NO CONCLUSION CAN BE DRAWN|nan||07/25/2006|||||R|717703.0||FWM|1.0||nan|Y||||||nan|||||||True
771497|7803688|N|1||SUSPECTED DEFLATION NO PRODUCT RETURNED NO PRODUCT RETURNED AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATIONS NO CONCLUSION CAN BE DRAWN|nan||10/04/2006|*||||R|746823.0||FWM|1.0||nan|Y||||||nan|||||||True
787717|7914398|N|1||REPORTED DEFECT SUSPECTED DEFLATION BACKGROUND NO INFO PROVIDED CONDITION UPON RECEIPT NO PRODUCT WAS RETURNED VISUAL INSPECTION NO PRODUCT WAS RETURNED PRODUCT INSPECTION AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATIONS CONCLUSION NO CONCLUSION CAN BE DRAWN|nan||11/08/2006|||||R|756844.0||FWM|1.0||nan|Y||||||nan|||||||True
778979|7982137|N|1||AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY  SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATION|nan||10/25/2006|*||||R|752811.0||FWM|1.0||nan|Y||||||nan|||||||True
742938|7795150|N|1||PRODUCT INSPECTION AS NO PRODUCT OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATIONS CONCLUSION NO CONCLUSION COULD BE DRAWN|nan||05/26/2006|||||R|696449.0||FWM|1.0||nan|Y||||||nan|||||||True
752949|15836395|N|1||AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATIONS VISUAL INSPECTION NO PRODUCT WAS RETURNED CONCLUSION NO CONCLUSION CAN BE DRAWN|nan||08/14/2006|||||R|723289.0||FWM|1.0||nan|Y||||||nan|||||||True
761208|7800465|N|1||AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATION REPORTED DEFECT SUSPECTED DEFLATION BACKGROUND NI CONDITION UPON RECEIPT NO PRODUCT RETURNED VISUAL INSPECTION NO PRODUCT WAS RETURNED CONCLUSION NO CONCLUSION CAN BE DRAWN|nan||09/06/2006|||||R|736499.0||FWM|1.0||nan|Y||||||nan|||||||True
761218|19635859|N|1||AS NO LOT NO WAS PROVIDED IT WAS NOT POSSIBLE TO REVIEW THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATION REPORTED DEFECT DEFLATION OF RIGHT BREAST IMPLANT BILATERAL EXCHANGE WITH MCGHAN DEVICES BACKGROUND ORIGINAL SURGERY WAS PERFORMED BY DR ON AN UNK DATE USING UNK HUTCHISON SALINE-FILLED IMPLANTS PT UNDERWENT BILATERAL REPLACEMENT SURGERY  IN 2006 THE IMPLANTS WERE REPLACED WITH MCGHAN STYLE 68HP 425CC DEVICES CONDITION UPON RECEIPT PRODUCT WAS RECEIVED IN A PEEL POUCH THE PACK INCLUDED DISTRIBUTORS REPORT AND HEALTH PROFESSIONALS PAPERWORK INCLUDING DECONTAMINATION CERTIFICATE VISUAL INSPECTION VISUAL INSPECTION IDENTIFIED A PATCH - SHELL TEAR APPROX 16MM IN LENGTH WHICH IS LOCATED BETWEEN THE 1 AND 3 OCLOCK POSITIONS WHEN THE PRODUCT WAS HELD IN SUCH A POSITION THAT THE BRAND NAME WAS UPRIGHT AND HORIZONTAL PRODUCT INSPECTION PRESSURE TESTING COULD NOT BE COMPLETED DUE TO THE SIZE AND POSITION OF THE TEAR MICROSCOPIC EXAMINATION 10X OF THE TEAR CONFIRMED IT FOLLOWS THE EDGE OF THE BARRIER PATCH ALTHOUGH THE EXACT CAUSE COULD NOT BE DETERMINED AS NO LOT NO WAS PROVIDED IT WAS NOT POSSIBLE TO PERFORM A REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATIONS CONCLUSION A CONCLUSION CAN NOT BE DRAWN|nan||09/06/2006|||||Y|736492.0||FWM|1.0||nan|Y||||||nan|||||||True
742617|7842192|N|1||NO PRODUCT RETURNED AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATION NO CONCLUSION CAN BE DRAWN|nan||06/13/2006|*||||R|706484.0||FWM|1.0||nan|Y||||||nan|||||||True
742933|7795149|N|1||VISUAL INSPECTION NO PRODUCT RETURNED PROUDCT INSPECTION AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATIONS CONCLUSION NO CONCLUSION COULD BE DRAWN|nan||05/26/2006|||||R|730743.0||FWM|1.0||nan|Y||||||nan|||||||True
778975|18697905|N|1||AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY  SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATION|nan||10/25/2006|||||R|752807.0||FWM|1.0||nan|Y||||||nan|||||||True
761221|7791819|N|1||AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATION REPORTED DEFECT SUSPECTED DEFLATION BACKGROUND NI CONDITION UPON RECEIPT NO PRODUCT RETURNED VISUAL INSPECTION NO PRODUCT WAS RETURNED CONCLUSION NO CONCLUSION CAN BE DRAWN|nan||09/06/2006|||||R|736502.0||FWM|1.0||nan|Y||||||nan|||||||True
754604|7834458|N|1||AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATION REPORTED DEFECT SUSPECTED DEFLATION BACKGROUND NI CONDITION UPON RECEIPT NO PRODUCT WAS RETURNED VISUAL INSPECTION NO PRODUCT WAS RETURNED CONCLUSION NO CONCLUSION CAN BE DRAWN|nan||08/22/2006|||||R|728564.0||FWM|1.0||nan|Y||||||nan|||||||True
742606|7791067|N|1||NO PRODUCT RETURNED AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATION NO CONCLUSION CAN BE DRAWN|*||06/13/2006|*||||Y|706478.0||FWM|1.0||nan|Y||||||nan|||||||True
754620|7801440|N|1||REPORTED DEFECT DEFLATION OF RIGHT BREAST IMPLANT UNILATERAL EXCHANGE WITH INAMED DEVICES BACKGROUND ORIGINAL SURGERY WAS PERFORMED BY DR HELLER IN THE MONTH OF MAY 2001 USING HUTCHISON HSH 0500CC SALINE-FILLED IMPLANTS WHICH WERE FILLED TO A VOLUME OF 0500CC WHICH IS WITHIN THE MAXIMUM FILL VOLUME LIMIT PT UNDERWENT BILATERAL REPLACEMENT SURGERY ON 71206 THE IMPLANTS WERE REPLACED WITH INAMED DEVICES CONDITION UPON RECEIPT PRODUCT WAS RECEIVED IN A PEEL POUCH THE PACK INCLUDED DISTRIBUTORS REPORT AND HEALTH PROFESSIONALS PAPERWORK INCLUDING DECONTAMINATION CERTIFCATE VISUAL INSPECTION VISUAL INSPECTION IDENTIFIED A TEAR ON THE VALVE - SHELL INTERFACE APPROX 5MM IN LENGTH WHICH IS LOCATED ON THE 6 OCLOCK POSITION WHEN THE PRODUCT WAS HELD IN SUCH A POSITON THAT THE BRAND NAME WAS UPRIGHT AND HORIZONTAL PRODUCT INSPECTION AS NO LOT NUMBER WAS PROVIDED IT WAS NOT POSSIBLE TO REVIEW THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATION PRESSURE TESTING COULD NOT BE COMPLETED DUE TO THE SIZE  POSITION OF THE BREACH MICROSCOPIC EXAMINATION X10 OF THE TEAR IDENTIFIED RAGGED EDGES WHICH IS INDICATIVE OF EXCESSIVE FORCE HAVING BEING USED CONCLUSION THE TEAR IS NOT A MFG FAULT|nan||08/22/2006|||||Y|728588.0||FWM|1.0||nan|Y||||||nan|||||||True
880844|7814875|N|1||AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPEC|nan||06/22/2007|||||R|854304.0||FWM|1.0||nan|Y||||||nan|||||||True
967555|8090281|N|1||NO PRODUCT WAS RETURNED AS NO PRODUCT WAS RETURNED OR LOT NO PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATION A CONCLUSION COULD NOT BE DRAWN|*||06/12/2006|||||R|937339.0||FWM|1.0||nan|Y||||||nan|||||||True
925246|8121660|N|1||REPORTED DEFECT UNILATERAL DEFLATION OF THE LEFT BREAST IMPLANT CONDITION OF PRODUCT NO PRODUCT WAS RETURNED BACKGROUND OF THE SURGERY ORIGINAL SURGERY WAS PERFORMED BY DR IN THE YRS BETWEEN 19981999 USING HUTCHISON 380 SALINE-FILL IMPLANTS THAT WERE FILLED TO AN UNK VOLUME ORIGINAL FILE HAS BEEN DESTROYED BY DR IN 2007 THE PT VISITED DRS CLINIC IN REGARDS TO A SUSPECTED DEFLATION OF THE LEFT BREAST IMPLANT THE PT UNDERWENT UNILATERAL REPLACEMENT SURGERY SIX DAYS LATER THE IMPLANTS WERE REPLACED WITH MENTOR 475CC DEVICES THAT WERE FILLED TO THE VOLUME OF 500CC CONCLUSION NO CONCLUSION CAN BE DRAWN AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT HAS NOT BEEN POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPEC|nan||09/20/2007|||||R|889579.0||FWM|1.0||nan|Y||||||nan|||||||True
967182|8093610|N|1||NO PRODUCT RETURNED AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATION NO CONCLUSION COULD BE DRAWN|nan||06/21/2006|||||R|936948.0||FWM|1.0||nan|Y||||||nan|||||||True
933832|8116854|N|1||AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPEC REPORTED DEFECT UNILATERAL DEFLATION OF THE RIGHT BREAST IMPLANT CONDITION OF PRODUCT NO PRODUCT WAS RETURNED BACKGROUND OF THE SURGERY ORIGINAL SURGERY WAS PERFORMED BY DR IN 1998 USING UNK HUTCHISON SALINE-FILL IMPLANTS WHICH WERE FILLED TO AN UNK VOLUME IN 2007 THE PT VISITED ANOTHER DR AT HIS CLINIC IN REGARDS TO A SUPSECTED DEFLATION OF THE RIGHT BREAST IMPLANT THE PT UNDERWENT BILATERAL REPLACEMENT SURGERY THE NEXT MONTH THE IMPLANTS WERE REPLACED WITH UNK DEVICES VISUAL INSPECTION NO PRODUCT WAS RETURNED PRODUCT INSPECTION NO PRODUCT WAS RETURNED CONCLUSION NO CONCLUSION CAN BE DRAWN|nan||10/19/2007|*||||R|903829.0||FWM|1.0||nan|Y||||||nan|||||||True
809888|7920916|N|1||DEFLATION OF UNILATERAL LEFT BREAST IMPLANT WILL REPLACE BILATERLLY VISUAL INSPECTION IDENTIFIED NO DAMAGE PRESSURE TESTING IDENTIFIED TWO BREACHES MEASURING APPROXIMATELY 1MM IN LENGTH WHICH ARE LOCATED ON THE ANTERIOR SURFACE APPROXIMATELY 8MM FROM THE VALVE STRAP AT THE 11 OCLOCK POSITIONWHEN THE PRODUCT WAS HELD IN SUCH A POSITION THAT THE BRAND NAME WAS UPRIGHT AND HORIZONTAL MICROSCOPIC EXAMINATION X10 OF THE BREACHES IDENTIFIED CELLAR INITIATION POINTS WHICH ARE INDICATIVE OF MECHANICAL TRAUMA AS NO LOT NO WAS PROVIDED IT WAS NOT POSSIBLE TO REVIEW THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATIONS CONCLUSION THE BREACHES ARE NOT MANUFACTURING FAULTS|nan||01/08/2007|||||Y|797372.0||FWM|1.0||nan|Y||||||nan|||||||True
925257|8113441|N|1||AS NO LOT NUMBER WAS PROVIDED IT HAS NOT BEEN POSSIBLE TO REVIEW THE MR004 MFG RECORD TO CONFIRM THAT THE PRODUCT WAS MFG WITHIN SPECIFICATIONS REPORTED DEFECT UNILATERAL DEFLATION OF THE RIGHT BREAST IMPLANT CONDITION OF PRODUCT PRODUCT WAS RECEIVED INSIDE A SINGLE SEALED PEEL POUCH WITH ACTIVATED STERILIZATION INDICATORS THE PACK INCLUDED DISTRIBUTORS REPORT AND HEALTH PROFESSIONALS PAPERWORK INCLUDING DECONTAMINATION CERTFICATE BACKGROUND OF THE SURGERY ORIGINAL SURGERY WAS PERFORMED BY DR ON AN UNDETERMINED DATE USING HUTCHISON HSL 420CC SALINE-FILL IMPLANTS WHICH WERE FILLED TO AN UNK VOLUME THE PT VISITED DR  CLINIC IN REGARDS TO A SUSPECTED DEFLATION OF THE RIGHT BREAST IMPLANT THE PT UNDERWENT BILATERAL REPLACEMENT SURGERY IN 2007 THE IMPLANTS WERE REPLACED WITH MENTOR 425CC DEVICES THAT WERE FILLED TO 450CC RIGHT AND 480CC LEFT VISUAL INSPECTION VISUAL INSPECTION IDENTIFIED A VALVE SHELL TEAR THAT MEASURES APPROX 4MM IN LENGTH WHICH IS LOCATED ON THE 6 OCLOCK POSITION WHEN THE PRODUCT WAS HELD IN SUCH A POSITION THAT THE BRAND NAME WAS UPRIGHT AND HORIZONTAL PRODUCT INSPECTION PRESSURE TESTING COULD NOT BE COMPLETED DUE TO THE SIZE AND POSITION OF THE TEAR MICROSCOPIC EXAMINATION X10 OF THE TEAR IDENTIFIED RAGGED EDGES WHICH ARE INDICATIVE OF AN EXCESSIVE FORCE HAVING BEING USED CONCLUSION THE TEAR IS NOT A MFG FAULT|nan||09/20/2007|||||Y|889577.0||FWM|1.0||nan|Y||||||nan|||||||True
961807|7896044|N|1||AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR A REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATIONS REPORTED DEFECT DEFLATION OF UNILATERAL LEFT BREAST IMPLANT BILATERAL REPLACEMENT WITH UNK DEVICES CONDITION OF PRODUCT NO PRODUCT WAS RETURNED BACKGROUND OF THE SURGERY NO INFO ON THIS COMPLAINT WAS RETURNED VISUAL INSPECTION NO PRODUCT WAS RETURNED CONCLUSION NO CONCLUSION CAN BE DRAWN AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR A REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATIONS|nan||11/29/2007|||||R|924519.0||FWM|1.0||nan|Y||||||nan|||||||True
920264|7853805|N|1||AS NO LOT NUMBER WAS PROVIDED IT WAS NOT POSSIBLE TO REVIEW THE RETAINED MFG RECORD MR004 TO CONFIRM THAT THE PRODUCT WAS MANUFACTURED WITHIN SPECS REPORTED DEFECT UNILATERAL DEFLATION OF THE RIGHT BREAST IMPLANT CONDITION OF PRODUCT PRODUCT WAS RECEIVED INSIDE A SINGLE SEALED PEEL POUCH WITH ACTIVATED STERILIZATION INDICATORS THE PACK INCLUDED DISTRIBUTORS REPORT AND HEALTH PROFESSIONALS PAPERWORK INCLUDING DECONTAMINATION CERTIFICATE BACKGROUND OF THE SURGERY ORIGINAL SURGERY WAS PERFORMED BY DR IN 1999 USING HUTCHISON HSL 380 SALINE-FILL IMPLANTS WHICH WERE FILLED TO AN UNCONFIRMED VOLUME AFTER WHICH IN 2007 THE PT VISITED ANOTHER DR IN REGARDS TO A SUSPECTED DEFLATION OF THE RIGHT BREAST IMPLANT THE PT UNDERWENT BILATERAL REPLACEMENT SURGERY SIXTEEN DAYS LATER THE IMPLANTS WERE REPLACED WITH MENTOR ROUND 450 GEL FILLED SMOOTH MODERATE-PROFILE DEVICES VISUAL INSPECTION VISUAL INSPECTION IDENTIFIED A VALVE SHELL TEAR THAT MEASURES APPROX 3MM IN LENGTH IS LOCATED ON THE 12 OCLOCK OF THE DEVICE WHEN THE PRODUCT WAS HELD IN SUCH A POSITION THAT THE BRAND NAME WAS UPRIGHT AND HORIZONTAL PRODUCT INSPECTION PRESSURE TESTING COULD NOT BE COMPLETED DUE TO THE SIZE AND POSITION OF THE TEAR MICROSCOPIC EXAMINATION X10 OF THE VALVE SHELL TEAR IDENTIFIED RAGGED EDGES WHICH ARE INDICATIVE OF AN EXCESSIVE FORCE HAVING BEING USED AS NO LOT NUMBER WAS PROVIDED IT WAS NOT POSSIBLE TO REVIEW THE RETAINED MFG RECORD MR004 TO CONFIRM THAT THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATIONS AS PREVIOUS SURGERY INFO WAS NOT KNOWN CONCLUSION THE TEAR IS NOT A MFG FAULT|nan||09/05/2007|||||Y|878035.0||FWM|1.0||nan|Y||||||nan|||||||True
978938|7933900|N|1||REPORTED DEFECT UNILATERAL DEFLATION OF THE LEFT BREAST IMPLANT CONDITION OF PRODUCT PRODUCT WAS RECEIVED INSIDE A SINGLE SEALED PEEL POUCH WITH ACTIVATED STERILIZATION I NDICATORS THE PACK INCLUDED DISTRIBUTORS REPORT AND HEALTH PROFESSIONALS PAPERWORK INCLUDING DECONTAMINATION CERTIFICATE BACKGROUND OF THE SURGERY ORIGINAL SURGERY WAS PERFORMED BY DR  IN 2000 USING HUTCHISON HSL 300 SALINE-FILL IMPLANTS THAT WERE FILLED TO A VOLUME OF 340CC WHICH IS WITHIN THE MAXIMUM FILL VOLUME LIMITS FOR THESE DEVICES AFTER WHICH IN 2007 THE PT VISITED THE SURGERY CENTRE IN REGARDS TO A SUSPECTED DEFLATION OF THE LEFT BREAST IMPLANT THE  PT ATTENDED THE CENTRE 3 MONTHS LATER TO REMOVE HER BREAST IMPLANTS THE PT ELECTED NOT TO UNDERGO BILATERAL REPLACEMENT SURGERY VISUAL INSPECTION VISUAL INSPECTION IDENTIFIED A FOLD FLAW THAT MEASURES APPROX 77MM IN LENGTH THE FOLD FLAW IS LOCATED ON THE ANTERIOR SURFACE IN WHICH IT EXTENDS OVER THE PERIPHERY AND ONTO THE POSTERIOR SURFACE WHERE IT DEVELOPS INTO A SPLIT WHICH MEASURES APPROX 2MM IN LENGTH PRODUCT INSPECTION PRESSURE TESTING IDENTIFIED NO OTHER LEAKS OR BREACHES MICROSCOPIC EXAMINATION X10 OF THE SHELL IDENTIFIED SIGNS OF FATIGUE ALONG THE FOLD AND AROUND THE SPLIT AS NO LOT WAS PROVIDED IT HAS NOT BEEN POSSIBLE TO PERFORM A REVIEW OF THE PRODUCT HISTORY SHEETS MR004  MFG RECORDS TO CONFIRM THAT THE PRODUCT WAS MANUFACTURED WITHIN SPEC CONCLUSION THE FOLD FLAW  SPLIT ARE NOT MFG FAULTS|nan||07/13/2007|||||Y|856182.0||FWM|1.0||nan|Y||||||nan|||||||True
1081485|7890580|N|1||BASED ON THE INFO PROVIDED TO MENTOR A PT EXPERIENCED BILATERAL BAKER GRADE 2 12 CAPSULAR CONTRACTURE FOLLOWING BREAST AUGMENTATION WITH SMOOTH SALINE-FILLED MAMMARY PROSTHESES IT WAS ALSO REPORTED THAT THE PT EXPERIENCED SYMPTOMS OF FATIGUE AND BRAIN FOG AND SCLERODERMA-TYPE SKIN RASHES ONE OF THE PTS EXPLANTED DEVICES WAS RETURNED TO MENTOR FOR EVAL THE DEVICE WAS FOUND TO BE INTACT WITH NO ANOMALIES BASED ON THE INFO PROVIDED PE CONCLUDED THE CAPSULAR CONTRACTURE IN THE PTS BREASTS WAS THE RESULT OF THE BODYS INDIVIDUAL PHYSIOLOGICAL RESPONSE TO THE IMPLANTATION OF A FOREIGN OBJECT IN SOFT TISSUE THE SEVERITY OF THIS CONDITION VARIES WITH EACH INDIVIDUAL CAPSULAR CONTRACTURE CAN MAKE THE BREAST HARDER AND FIRMER THAN DESIRABLE WHICH MAY RESULT IN BREAST ASYMMETRY DISCOMFORT OR PAIN THIS CONDITION HAS ALSO BEEN ASSOCIATED WITH DEVICE DEFLATION WRINKLING ANDOR DISPLACEMENT OF THE PROSTHESIS CONCERN OVER THE ASSOCIATION OF BREAST IMPLANTS TO THE DEVELOPMENT OF AUTOIMMUNE OR CONNECTIVE TISSUE DISEASES SUCH AS LUPUS SCLERODERMA OR RHEUMATOID ARTHRITIS WAS RAISED BECAUSE OF CASES REPORTED IN THE LITERATURE WITH SMALL NUMBERS OF WOMEN WITH IMPLANTS A REVIEW OF SEVERAL LARGE EPIDEMIOLOGICAL STUDIES OF WOMEN WITH AND WITHOUT IMPLANTS INDICATES THAT THESE DISEASES ARE NO MORE COMMON IN WOMEN WITH IMPLANTS THAN THOSE IN WOMEN WITHOUT IMPLANTS BASED ON THESE STUDIES PE IS UNABLE TO CONFIRM THAT THE REPORTED SYMPTOMS ARE DEVICE RELATED HOWEVER MENTOR CONTINUES TO INCLUDE EXTENSIVE DISCUSSIONS ON ALLEGED SILICONE RESPONSES IN ITS PRODUCT INSERT DATA SHEETS SO THAT THE PT AND PHYSICIAN ARE FULLY INFORMED OF ANY POTENTIAL RISKS ADDITIONALLY TRENDS FOR ALL COMPLAINTS OF SYSTEMIC DISEASE ANDOR RESPONSES WILL CONTINUE TO BE MONITORED BY MENTOR QUALITY ASSURANCE|SALINE-FILLED MAMMARY PROSTHESIS|350-1650|07/21/2008|V|05/13/2008|DA|R|Y|1048916.0|0HP|FWM|1.0||MAMMARY PROSTHESIS|N|5546183/5548960|||IRVING|US|MENTOR||TX|||||True
1422415|1090268|D|1||HEALTH PROFESSIONAL REPORTED A RIGHT SIDE INFLATION FOLLOW-UP FINDINGS PHYSICIAN SUSPECTS SEROMA SURGERY IS PENDING AND WILL CONFIRM ACTUAL EVENT|STYLE 68 SALINE FILLED BREAST IMPLANT|68-330|07/24/2009|||DA|N|R||0HP|FWM|1.0|01/18/2012|nan||1558071|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
1407268|16028851|D|1||RIGHT MENTOR BREAST IMPLANT IS RUPTURED LEFT BREAST HAS A NODULE THAT NEEDS TO BE REMOVED AS SUGGESTED BY 3 DRS I HAVE SEVERE PAIN CANT SLEEP GET FEVERS DIZZY WEAK THE BREAST IS SMALLER AND SAGGING ITS BEEN NEARLY 2 MONTHS SINCE IVE KNOWN AND BEEN TO A GENERAL SURGEON WHO SENT ME TO THE PLASTIC SURGEON WHO WONT REMOVE THE IMPLANTS UNTIL THE NODULE IS REMOVED THE GENERAL SURGEON WONT REMOVE THE NODULE WHILE IMPLANTS ARE IN PLASTIC SURGEON SAYS I NEED TO SEE A BREAST SPECIALIST BUT CANT EVEN NAME ONE IN HAWAII IVE HAS 2CT SCANS ULTRASOUND AND BREAST MRI TO CONFIRM THIS IM CAUGHT IN THE MIDDLE OF A MESS AND MY SYMPTOMS ARE WORSENING DAILY MY WORK AND PERSONAL LIFE AT A HALT DUE TO MY SYMPTOMS EACH DR ON ISLAND HAS DONE NOTHING BUT GIVE ME PAIN MEDS AND ANTIBIOTICS AND REFER ME BACK TO OTHER DRS MY HEALTH INSURANCE COMPANY HAS DIRECTED ME TO SEE THESE DRS AND NOW IM AT A DEAD END GETTING SICKER I NEED SOME SORT OF IDEA OR HELP OF WHAT TO DO BEFORE THIS BECOMES EVEN WORSE IM DESPERATE FOR HELP AS WE HAVE LIMITED RESOURCES THE DR THAT PUT IN THE IMPLANT WILL NOT RELEASE MY OPERATIVE REPORT AND THE LOT  AND STYLE UNLESS I PROVIDE A CASH OR CREDIT CARD DEPOSIT MENTOR IS THE BRAND AND WERE PUT IN 2005|MENTOR||06/19/2009||||N|||0|FWM|1.0||BREAST IMPLANT|||||||nan|||||||True
1456292|1193939|D|1||FEMALE WITH HISTORY OF BILATERAL BREAST IMPLANTS THE PT NOTED CONTRACTURE TO RIGHT BREAST SHE WAS EXAMINED BY HER SURGEON TO CONFIRM DIAGNOSIS OF CAPSULAR CONTRACTURE OF THE RIGHT BREAST THE PT UNDERWENT BILATERAL IMPLANT EXCHANGE DURING THIS HOSPITALIZATION ADDENDUM DELAY OF REPORT DATE DUE TO WAITING FOR RETURN CALL FROM FDA CONSULTANT TO ADVICE ON WHETHER REPORT SHOULD BE FILED AS MANDATORY OR VOLUNTARY|SALINE BREAST IMPLANT|25-68301|08/19/2009|||106 MO|Y|*||0HP|FWM|1.0||BREAST IMPLANT||NH7307|700 WARD DR.||SANTA BARBARA|US|MCGHAN MEDICAL|93111 2936|CA|93111|293|||True
1995973|1712762|D|1||PT REPORTS THAT HER RIGHT BREAST IMPLANT HAS MALFUNCTIONED SHE HAS NOT HAD A PHYSICIAN CONFIRM BUT HAD PAIN SEVERAL DAYS BEFORE AND THEN NOTED HER RIGHT BREAST WAS ABOUT A B CUP WHILE HER LEFT BREAST REMAINS A D CUP NO FURTHER PAIN JUST ASYMMETRICAL|MENTOR ROUND SALINE SMOOTH||02/14/2011||||N|||0LP|FWM|1.0||BREAST IMPLANT||350-2275|201 MENTOR DR||SANTA BARBARA|US|MENTOR WORLDWIDE LLC|93111|CA|93111||||True
2348477|62765167|D|1||HEALTHCARE PROFESSIONAL REPORTED A CASE OF ANAPLASTIC LARGE CELL LYMPHOMA WHICH WILL BE CAPTURED AS LYMPHOMA AS THERE IS NO PATHOLOGY REPORT AVAILABLE TO CONFIRM THE DIAGNOSIS OF ALCL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/30/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2254949|21232959|N|1||AS NO PRODUCT WAS RETURNED OR LOT NUMBER PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MFG WITHIN SPECIFICATION NO CONCLUSION CAN BE DRAWN|HUTCHINSON IMPLANT||02/05/2007|||DA||R||0|FWM|1.0||IMPLANT|||||||nan|||||||True
2348522|61100522|D|1||HEALTHCARE PROFESSIONAL REPORTED VIA MEDWATCH LEFT SIDE GRADUAL ELEVATION OF THE IMPLANT LOCATION ADDITIONAL INFORMATION NOTED AS LEFT SIDE DEVICE RIGIDLY AFFIXED TO PATIENTS CHEST WALL NO PATHOLOGY REPORT PROVIDED TO CONFIRM THE DIAGNOSIS OF ALCL THEREFORE THE EVENT WILL BE CAPTURED AS LYMPHOMA|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2264070|2198895|D|1||B6 2011 RE BREAST IMPLANT RUPTURE B6-2011 - B6 B6 I HAD MENTOR BREAST IMPLANTS ON B6-2002 BY DR B6 AROUND B6 2011 I NOTICED THAT MY RIGHT BREAST SEEMED TO BE GETTING SMALLER THEN ON B6-2011 I BEGAN TO HAVE PAIN AND COULD FEEL LUMPS IN THE RIGHT BREAST SO I MADE AN APPOINTMENT WITH DR B6 FOR THE NEXT DAY B6-2011 ON THAT DAY DR B6 AFTER EXAMINATION SCHEDULED ME FOR A 700AM OPERATION ON SATURDAY B6-2011 BECAUSE THE RIGHT BREAST WAS RUPTURED AND HE WAS VERY CONCERNED DR B6 FELT THE URGENCY TO PERFORM THE OPERATION ONLY 2 DAYS AFTER INITIAL VISIT PLEASE NOTE HIS CONCERN WAS URGENT ENOUGH THAT HE PERFORMED THE SURGERY ON SATURDAY WHEN THE OPERATING ROOM IS NOT NORMALLY IN USE DUE TO THE SEVERITY OF THE RUPTURE I DID NOT HAVE TIME TO CONTACT DR B6 TO CONFIRM WHAT TYPE IMPLANTS HE INITIALLY INSTALLED WHEN DR B6 OPENED MY CHEST CAVITY TO VIEW THE IMPLANT HE STATED IN HIS REPORT THAT THERE WAS NO MANUFACTURER NAME NOR SERIAL NUMBER ON THE IMPLANT THEREFORE DR B6 IMPLANTED WHAT HE BELIEVED TO BE CLOSEST TO PRODUCT CURRENTLY USED HAD WE KNOWN THE PRODUCT WAS MENTOR AND HAD WE BEEN GIVEN ANY WARRANTY INFORMATION FROM DR B6 WE CERTAINLY WOULD HAVE USED MENTOR PRODUCTS FOR REPLACEMENT NO WARRANTY INFORMATION WAS GIVEN TO US OR EVEN MENTIONED TO CHECK THE MENTOR WEBSITE BY DR B6 I HAD NO IDEA THAT BREAST IMPLANTS OFFERED LIMITED WARRANTIES UNTIL DR B6 MENTIONED THAT I SHOULD CONTACT MENTOR TO GET MY WARRANTIED PRODUCT CLAIM STARTED PLEASE NOTE REPORT OF OPERATION FROM DR B6 WAS FAXED TO ME ON B6-2011 DR B6 RECORDED THE FOLLOWING IN HIS NOTES RUPTURED RIGHT BREAST IMPLANT WITH SEVERE CALCIFICATION OF RIGHT BREAST CAPSULE WHICH WAS REMOVED LEFT BREAST WAS ALSO REMOVED AND REPLACED AND IT WAS NOTED THAT IT WAS A 275CC IMPLANT FILLED TO 301CC AND NEITHER IMPLANT HAD A SERIAL NUMBER DUE TO THE RUPTURING OF THE IMPLANT AND THE CALCIFICATION ON THE RIGHT BREAST I AM CONCERNED ABOUT MY FUTURE HEALTH AND MEDICAL ISSUES FROM THE RUPTURED IMPLANT IN ADDITION I AM VERY CONCERNED BY THE FACT THAT NO MANUFACTURER NAME OR SERIAL NUMBER WAS ON EITHER IMPLANT AS I NOW UNDERSTAND THAT THIS IS THE INFORMATION UTILIZED FOR RECALL PURPOSES I HAVE CONSULTED YOUR MENTOR WEBSITE WARRANTY INFORMATION WHICH STATES THE FIRST BREAST IMPLANT MANUFACTURER IN THE INDUSTRY TO OFFER A LIMITED WARRANTY ON ALL OUR BREAST IMPLANTS AND FURTHER STATES ALL MENTOR BREAST IMPLANTS COME WITH A FREE LIMITED WARRANTY PROGRAM THAT OFFERS LIFETIME PRODUCT REPLACEMENT AND LIMITED FINANCIAL ASSISTANCE IF NEEDED BECAUSE YOUR PEACE OF MIND COMES FIRST I HAVE ALSO CONSULTED THE WEBSITE OF DR B6 FROM THE B6 THE WEBSITE HAS A BREAST IMPLANT OFFER FOR B6 2011 HIS PARTICULAR AD STATES IN PART MANUFACTURERS MENTOR AND ALLERGAN OFFER A LIFETIME WARRANTY ON THEIR IMPLANTS IN THE EVENT OF IMPLANT RUPTURE AND IF THE RUPTURE OCCURS WITHIN THE FIRST 10 YEARS OF IMPLANTATION BOTH MENTOR AND ALLERGAN OFFER A FINANCIAL WARRANTY OF B6 WHEN I SPOKE TO A MENTOR REPRESENTATIVE ON THE PHONE SHORTLY AFTER MY RETURN HOME FROM SURGERY I WAS TOLD MY SPECIFIC IMPLANTS HAD NO WARRANTY I QUESTIONED WHY THERE WERE NO SERIAL NUMBERS OR THE MENTOR BRAND NAME ON EITHER IMPLANT AND ASKED THE REPRESENTATIVE ISNT THIS INFORMATION NEEDED AND USED FOR RECALLS SHE ABRUPTLY INFORMED ME THAT THE IMPLANTS IN QUESTION HAD NEVER HAD A RECALL OTHER THAN THE YEAR AND DATE OF INSTALLATION B6-2002 THE REPRESENTATIVE HAD NO ADDITIONAL INFORMATION TO REFERENCE WHETHER THERE HAD BEEN A RECALL MADE ON THIS IMPLANT PRODUCT I AM REQUESTING THAT MENTOR DO THE FOLLOWING TO HONOR THEIR WRITTEN STATED WARRANTY REIMBURSE ME THE COST OF THE IMPLANTS SINCE THERE WAS NO BRAND DESCRIPTION OR SERIAL NUMBER ON THE ORIGINAL PRODUCT AND SINCE THE URGENCY OF THE RUPTURE LEFT NO TIME FOR ME TO CONTACT THE ORIGINAL PHYSICIAN DR B6 REIMBURSEMENT OF THE FINANCIAL WARRANTY IN EVENT OF IMPLANT RUPTURE WITHIN THE FIRST 10 YEARS OF IMPLANTATION OF B6|MENTOR|NOT ON PRODUCT|09/08/2011||||Y|||0HP|FTR|1.0||BREAST IMPLANT||NOT ON PRODUCT|201 MENTOR DRIVE|CONSUMER AFFAIRS DEPARTMENT|SANTA BARBARA|US|MENTOR WORLDWIDE LLC|93111|CA|93111||NOT ON PRODUCT|NOT ON PRODUCT|True
2702777|2802178|D|1||PT REPORTS LYMPHOMA ON THE BREAST IMPLANT FU STUDY ANNUAL QUESTIONNAIRE A CALL WAS PLACE TO THE PHYSICIAN TO GATHER MORE INFO THEY WERE ABLE CONFIRM THE DIAGNOSIS OF NON-HODGKINS THAT THIS PT WAS IN FACT AN AUGMENTATION PT AND THAT THEY WERE NOT AWARE OF A DIAGNOSIS OF LYMPHOMA THE DISEASE IS NOT BREAST SIDE SPECIFIC IT IS A SYSTEMIC LYMPHOMA THIS IS FOR THE LEFT SIDE MFR  2024601-2012-0063 IS FOR THE RIGHT SIDE|STYLE 20 SILICONE GEL FILL BREAST IMPLANT|20-325|08/13/2012|||DA|N|R||0HP|FTR|1.0|03/31/2014|nan||1721856|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2675981|18977587|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF SUSPICIOUS OF SEROMA-ASSOCIATED ALCL IT IS NOT COMPLETELY CLEAR WHICH SIDE IS AFFECTED AT THIS TIME THE LYMPHOMA WILL BE REPRESENTED ON THE RIGHT SIDE AND THE LEFT SIDE IS NOTED AS A REMOVAL ONLY THERE IS NO DEVICE INFORMATION PATHOLOGY CYTOLOGY NOR IS THERE CLARIFICATION OF THE AFFECTED SIDE NOTED AT THIS TIME MULTIPLE ATTEMPTS HAVE BEEN MADE TO CONFIRM THE AFFECTED SIDE AND TO GATHER ANY ADDITIONAL INFORMATION ON THIS CASE ANY ADDITIONAL INFORMATION REGARDING THESE EVENTS WILL BE UPDATED IN THIS FILE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|07/26/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN|93117|CA|93117||||True
2337179|2356522|D|1||RECEIVED A VOLUNTARY MEDWATCH FORM B4 WHERE THE PT REPORTED I HAD BILATERAL SILICONE IMPLANTS IMPLANTED IN 1990 I DEVELOPED SWELLING AND REDNESS OF THE RIGHT BREAST IN 2002 FOLLOWED BY ENLARGED LYMPH NODES AND SKIN NODULES I WAS DIAGNOSED WITH NODULAR SCLEROSIS HODGKINS OF THE RIGHT MAXILLARY WHICH SPREAD TO THE SKIN SIX MONTHS LATER THIS WAS TREATED WITH CHEMO AND RADIATION HOWEVER TWO MONTHS LATER IT RECURRED I WAS TREATED WITH STEM CELL TRANSPLANT AND WITHIN 60 DAYS DEVELOPED A 7CM TUMOR OF CHEST WALL SURROUNDING THE RIGHT BREAST IMPLANT AND ENLARGED ANTERIOR MAXILLARY LYMPH NODES THIS WAS DIAGNOSED AS A RECURRENCE AND TREATED WITH MORE RADIATION FOUR MONTHS LATER I DEVELOPED MULTIPLE PAINFUL BLISTERING LESIONS ON THE RIGHT BREAST THESE WERE MULTIPLE AND DIAGNOSED ALCL THE ONCOLOGIST AND PATHOLOGIST SAID THERE WAS A STRONG POSSIBILITY THAT THE PREVIOUS DIAGNOSIS OF HODGKINS DISEASE WAS INCORRECT AND INDEED I COULD HAVE HAD A SYSTEMIC ALCL ALL ALONG AFTER READING ABOUT THE ASSOCIATION BETWEEN ALCL AND BREAST IMPLANTS I WANTED TO MAKE SURE MY CASE IS INCLUDED FOR RESEARCH PURPOSES THERE WAS NO CORRELATION BETWEEN THE IMPLANT AND THE DISEASE AT THE TIME SO I DID NOT HAVE TO REMOVED UNTIL 2008 FU CALLS WERE MADE TO THE SURGEONS OFFICE TO GATHER ADDITIONAL INFO BUT THEY WERE UNABLE TO PROVIDE ANY DEVICE INFO THE SURGEON INFORMS PRODUCT SUPPORT THAT HE WAS NOT AWARE OF THE PTS DIAGNOSIS OF ALCL ANOTHER CALL WAS PLACED TO THE PT WHO WAS ABLE TO PROVIDE HER PATHOLOGY REPORT TO CONFIRM THE DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/26/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2510537|9720102|N|1||SPECTRUM DESIGNS INITIAL ANALYSIS WAS TO REVIEW THE BATCH AND STERILIZATION RECORDS FOR ANY DISCREPANCY TO EXPLAIN THE INCIDENT NONE WERE OBSERVED A DUROMETER TEST WAS PERFORMED ON THE RETURNED DEVICE TO CONFIRM THAT THE MATERIAL WAS MADE TO SPECIFICATIONS AS RECORDED ON THE BATCH RECORD A LATERAL TEAR IN THE UPPER THIRD OF THE IMPLANT WAS OBSERVED WHICH WAS NEARLY THROUGH THE IMPLANT TWO DACRON VELOUR STRIPS WERE INTACT ON THE BACK OF THE IMPLANT TO AID IN FIXATION VIA TISSUE INGROWTH THESE STRIPS WERE ADDED TO THE DESIGN OF THE IMPLANT PER THE PHYSICIANS REQUEST THE TEAR OCCURRED AT THE SUPERIOR BORDER OF THESE STRIPS IT IS PLAUSIBLE THAT TISSUE FIXATION FROM THE DACRON WHICH WOULD HAVE SECURED THE IMPLANTS LOWER 23 ALLOWED MOVEMENT IN THE UPPER THIRD DUE TO MOVEMENT DURING EXERCISE ETC IT IS ALSO POSSIBLE THAT THE POCKET DISSECTION DURING IMPLANTATION WAS TOO SMALL FOR THE DEVICE WHICH WOULD HAVE ALLOWED THE DEVICE TO BUCKLE AND MAY HAVE EXPLAINED THE PTS CONCERN ABOUT THE INFERIOR EDGE CONSULTATION WITH DR B6 REGARDING THE REMAKING OF THE DEVICE RESULTED IN MODIFICATION TO THE ORIGINAL DESIGN SPECIFICATIONS THE DEVICE WAS REMADE IN A SOFT DUROMETER AND 4 DACRON PATCHES APPROX 15 CM IN DIAMETER WOULD BE ATTACHED EQUAL DISTANCE ON THE POSTERIOR SURFACE OF THE IMPLANT IN ADDITION 4 SUTURE LOOPS WERE ALSO PLACED FOR FIXATION THE CUSTOM IMPLANT WAS RE-MANUFACTURED AT A FIRMER DUROMETER THAN THE ORIGINAL SPECIFICATION|nan|CUSTOM IMPLANT|03/27/2012||02/13/2012||Y|Y||0HP|FWM|1.0|05/31/2014|CUSTOM SOLID SILICONE IMPLANT||33911|||CARPINTERIA|US|SPECTRUM DESIGNS MEDICAL||CA|||CUSTOM IMPLANT|PT. CROSS|True
2702778|2791994|D|1||PT REPORTED LYMPHOMA ON THE BREAST IMPLANT FOLLOW UP STUDY ANNUAL QUESTIONNAIRE A CALL WAS PLACED TO THE PHYSICIAN TO GATHER MORE INFO THEY WERE ABLE TO CONFIRM THE DIAGNOSIS OF NON-HODGKINS THAT THIS PT WAS IN FACT AN AUGMENTATION PT AND THAT THEY WERE NOT AWARE OF A DIAGNOSIS OF LYMPHOMA THE DISEASE IS NOT BREAST SIDE SPECIFIC IT IS A SYSTEMIC LYMPHOMA THIS IS FOR THE RIGHT SIDE MFR  2024601-2012-00759 IS FOR THE LEFT|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-325|08/13/2012|||DA|N|R||0HP|FTR|1.0|03/31/2014|nan||1721856|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2565510|2651408|D|1||FATIGUE IMMUNE DEFICIENCY DISEASE EXTREME HAIR LOSS EXTENSIVE PSORIASIS SEIZURES HEART PALPITATIONS WEIGHT GAIN FIBROMYALGIA CHRONIC FATIGUE INSOMNIA ANXIETY DEPRESSION JOINT PAIN PATIENT STATES SHE HAS SILICON TOXICITY DAUGHTER SUFFERED FROM TAINTED BREAST MILK DR B6 UNABLE TO CONFIRM PRODUCT EXPERIENCE|SALINE SMOOTH ROUND MODERATE PROFILE|350-1660|05/03/2012||||N|R||0HP|FWM|1.0||MAMMARY PROSTHESES||5675234|||IRVING|US|MENTOR||TX|||||True
2565511|2750768|D|1||FATIGUE IMMUNE DEFICIENCY DISEASE EXTREME HAIR LOSS EXTENSIVE PSORIASIS SEIZURES HEART PALPITATIONS WEIGHT GAIN FIBROMYALGIA CHRONIC FATIGUE INSOMNIA ANXIETY DEPRESSION JOINT PAIN PATIENT STATES SHE HAS SILICON TOXICITY DAUGHTER SUFFERED FROM TAINTED BREAST MILK DR B6 UNABLE TO CONFIRM PRODUCT EXPERIENCE|SALINE SMOOTH ROUND MODERATE PROFILE|350-1660|05/03/2012||||N|R||0HP|FWM|1.0||MAMMARY PROSTHESES||5709584|||IRVING|US|MENTOR||TX|||||True
2674277|16325445|N|1||A REPORT WAS MADE TO MENTOR BY THE EXPLANTING PHYSICIAN THAT THIS PT WAS EXPERIENCING SYMPTOMS OF MS NUMBNESS IN LEGS AND DIFFICULTY WALKING SINCE HER DEFLATION IN B6 2005 THE PT WAS RE-IMPLANTED AT THAT TIME WITH MENTOR SALINE-FILLED MAMMARY PROSTHESES SHE HAS ALSO PRESENTED WITH A RIGHT DEFLATION SINCE REMOVING THESE DEVICES THE PTS SYMPTOMS HAVE SUBSIDED AND THE PT CAN WALK BECAUSE THE LEFT PROSTHESIS INVOLVED IN THIS COMPLAINT WILL NOT BE RETURNED TO MENTOR PE WAS PRECLUDED FROM EVALUATING THE DEVICE BASED ON THE LABORATORY EVAL PE CONCLUDED THE RIGHT DEFLATION WAS MOST LIKELY DUE TO THE RENT THAT MEASURED APPROX 1 CM IN LENGTH WITHIN THE CREASE ON THE POSTERIOR ASPECT OF THE DEVICE A MICROSCOPIC EXAMINATION OF THE EDGES OF THE RENT REVEALED A TAPERED WEAR PATTERN TAPER WEAR IS CHARACTERISTIC OF A CREASEFOLD FAILURE A CREASEFOLD FAILURE IS A KNOWN INHERENT RISK ASSOCIATED WITH THE USE OF SALINE-FILLED MAMMARY PROSTHESES AND MAY BE THE RESULT OF ONE OR MORE OF THE FOLLOWING CONTRIBUTING FACTORS UNDERINFLATION OR OVERINFLATION OF THE DEVICE CONTINUOUS AND SUSTAINED STRESSES TO THE DEVICE - SUCH AS CAPSULAR CONTRACTURE OR TOO SMALL A BREAST POCKET AND FOLDING OR WRINKLING OF THE SHELL IN THE BREAST POCKET LEAK TESTING OF THE DEVICE REVEALED NO OTHER LEAKAGE SITES BECAUSE THE RISK OF DEVICE DEFLATION CANNOT BE ELIMINATED MENTOR ADDRESSES THIS RISK IN THE PIDS BY STATING THAT THESE DEVICES SHOULD NOT BE CONSIDERED LIFETIME DEVICES THE MENTOR MICROBIOLOGY DEPT ASSURES THE STERILITY OF DEVICES INDICATING THAT THEY MEET ALL STERILIZATION PARAMETERS REQUIRED TO PROVIDE A 10E-6 STERILITY ASSURANCE LEVEL PRIOR TO RELEASE FOR DISTRIBUTION PE CONCLUDED THE REPORTED INFECTION IN THE PTS BREAST OCCURRED FROM A SOURCE OTHER THAN THE DEVICES INFECTION IS A KNOWN COMPLICATION ASSOCIATED WITH ANY SURGERY AND IS REFERENCED IN OUR CURRENT PRODUCT INSERT DATA SHEET THE INSTITUTE OF MEDICINE IOM OF THE NATIONAL ACADEMY OF SCIENCE RELEASED A FINAL REPORT STATING A REVIEW OF SEVENTEEN EPIDEMIOLOGICAL REPORTS OF CONNECTIVE TISSUE DISEASE IN WOMEN WITH BREAST IMPLANTS WAS REMARKABLE FOR ITS CONSISTENCY IN FINDING NO ELEVATED RISKS OR ODDS RATIO FOR AN ASSOCIATION OF IMPLANTS WITH DISEASETHERE IS NO EVIDENCE THAT SILICONE IMPLANTS ARE RESPONSIBLE FOR ANY MAJOR DISEASE OF THE WHOLE BODY WOMEN ARE EXPOSED TO SILICONE CONSTANTLY IN THEIR DAILY LIVES THERE IS NO PLAUSIBLE EVIDENCE OF A NOVEL AUTOIMMUNE DISEASE CAUSED BY IMPLANTS BASED ON THESE REPORTS PE IS UNABLE TO CONFIRM THAT THE REPORTED COMPLAINTS ARE DEVICE RELATED HOWEVER MENTOR CONTINUES TO INCLUDE EXTENSIVE DISCUSSIONS ON ALLEGED SILICONE RESPONSES IN ITS PRODUCT INSERT DATA SHEETS SO THAT THE PT AND PHYSICIAN ARE FULLY INFORMED OF ANY POTENTIAL RISKS MENTOR BELIEVES ITS CURRENT CONTROLS ARE ADEQUATE ADDITIONALLY TRENDS FOR ALL COMPLAINTS OF SYSTEMIC DISEASE ANDOR RESPONSES WILL CONTINUE TO BE MONITORED BY MENTOR QUALITY ASSURANCE|SMOOTH SALINE-FILLED MAMMARY PROSTHESIS|350-1630|07/23/2012||05/02/2012|DA|Y|*||0HP|FWM|1.0||MAMMARY PROSTHESIS||5548450|||IRVING|US|MENTOR WORLDWIDE LLC||TX|||||True
3165371|62390606|D|1||HEALTH PROFESSIONAL REPORTED  A SUBPECTORAL SALINE IMPLANT IS IDENTIFIED ON THE RIGHT CAPSULAR INFOLDING - CAPSULAR CONTRACTURES ARE IDENTIFIED A SMALL-MODERATE VOLUME OF FLUID IS SEEN AROUND THE IMPLANT ADDITIONALLY PATIENT REPORTS TO HEALTH PROFESSIONAL ITCHING OF THE RIGHT BREAST PATIENT HAD A MASTECTOMY TEN YEARS AGO POST OP PATIENT HAD A MILD INFECTION WHICH RESOLVED WITH ANTIBIOTICS PATIENT WAS RECENTLY DIAGNOSED WITH SUPRACLAVICULAR AND AXILLARY LYMPHADENOPATHY RECENT PET THAT SHOWED ENLARGED RIGHT EPITROCHLEAR LYMPH NODE THE BIOPSY SHOWED HODGKIN LYMPHOMA NODULAR SCLEROSIS BONE MARROW BIOPSY WAS NEGATIVE FOR LYMPHOMA PATIENT WAS TREATED WITH ABVD SUBSEQUENT SPECIMENS REVIEW HERE FROM PERI-PROSTHETIC FLUID OF THE RIGHT CHEST WAS REPORTED AS ATYPICAL LYMPHOID CELLS MOST CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA IN PERIPROSTHETIC FLUID AND SUBSEQUENT EXCISIONAL BIOPSY OF THE RIGHT BREAST CAPSULE IMMUNOHISTOCHEMICAL STAINS SHOW THAT THE ATYPICAL LYMPHOID CELLS ARE POSITIVE FOR CD15 AND CD30 THESE FINDINGS RAISE THE POSSIBILITY OF HODGKINS LYMPHOMA PATHOLOGICAL MARKERS DID NOT CONFIRM ALCL EVENT WILL BE CAPTURED AS LYMPHOMA DEVICE WAS REMOVED AND PATIENT HAD A PARTIAL CAPSULECTOMY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/07/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3165371|62391233|D|1||HEALTH PROFESSIONAL REPORTED  Â¿A SUBPECTORAL SALINE IMPLANT IS IDENTIFIED ON THE RIGHT CAPSULAR INFOLDING Â¿ CAPSULAR CONTRACTURES ARE IDENTIFIED A SMALL-MODERATE VOLUME OF FLUID IS SEEN AROUND THE IMPLANTÂ¿ ADDITIONALLY PATIENT REPORTS TO HEALTH PROFESSIONAL Â¿ITCHING OF THE RIGHT BREASTÂ¿PATIENT HAD A MASTECTOMY TEN YEARS AGOÂ¿POST OP PATIENT HAD A MILD INFECTION WHICH RESOLVED WITH ANTIBIOTICSÂ¿ PATIENT WAS RECENTLY DIAGNOSED WITH SUPRACLAVICULAR AND AXILLARY LYMPHADENOPATHY Â¿RECENT PET THAT SHOWED Â¿ENLARGED RIGHT EPITROCHLEAR LYMPH NODEÂ¿ THE BIOPSY SHOWED Â¿HODGKIN LYMPHOMA NODULAR SCLEROSIS BONE MARROW BIOPSY WAS NEGATIVE FOR LYMPHOMA PATIENT WAS TREATED WITH ABVD SUBSEQUENT SPECIMENS REVIEW HERE FROM PERI-PROSTHETIC FLUID OF THE RIGHT CHEST WAS REPORTED AS ATYPICAL LYMPHOID CELLS MOST CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA IN PERIPROSTHETIC FLUID AND SUBSEQUENT EXCISIONAL BIOPSY OF THE RIGHT BREAST CAPSULE IMMUNOHISTOCHEMICAL STAINS SHOW THAT THE ATYPICAL LYMPHOID CELLS ARE POSITIVE FOR CD15 AND CD30 THESE FINDINGS RAISE THE POSSIBILITY OF HODGKINÂ¿S LYMPHOMAÂ¿ PATHOLOGICAL MARKERS DID NOT CONFIRM ALCL EVENT WILL BE CAPTURED AS LYMPHOMA DEVICE WAS REMOVED AND PATIENT HAD A PARTIAL CAPSULECTOMY|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/07/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3362400|3927432|D|1||I HAD INAMED ALLERGAN SILICONE BREAST IMPLANTS INSERTED ON B6 2007 APPROX 2 WEEKS AGO LATE B6 2013 I NOTICED A PALPABLE MASS IN MY LEFT AXILLA LYMPH NODES MY OBGYN CONFIRMED CAUSE FOR CONCERN AND INSTRUCTED ME TO HAVE A MAMMOGRAM AND SONOGRAM TO DETERMINE CAUSE OF THE MASS ON B6 2013 RADIOLOGIST CONFIRMED A HIGHLY ECHOGENIC MASS VIA SONOGRAM 21CM X 14CM X 5MM IN SIZE AND RECOMMENDED NEEDLE BIOPSY TO CONFIRM PATHOLOGY NEEDLE BIOPSY ON B6 2013 CONFIRMED LYMPH NODE CONTAINING FOREIGN BODY REACTION TO REFRACTILE NON-POLARIZABLE MATERIAL CONSISTENT WITH SILICONE CONSULTATION WITH TWO PLASTIC SURGEONS ORIGINAL SURGEON AND A SECOND OPINION CONFIRM IN THEIR OPINION EXTRA-CAPSULAR RUPTURE IN LEFT SIDE WHERE LUMP IS AND POSSIBLE INTRA-CAPSULAR OR EXTRA-CAPSULAR RUPTURE IN RIGHT SIDE AS WELL DENSE LYMPH NODES WERE ALSO NOTED ON THAT SIDE IN THE SONOGRAM BUT NOT AS LARGE AS ON THE LEFT I AM CONCERNED THAT I WOULD HAVE THIS TYPE OF COMPLICATION ONLY 6 YEARS AFTER INSERTION AND FELT IT SHOULD BE REPORTED|SILICONE IMPLANTS|110-240|09/17/2013|||||||0LP|FTR|1.0||SILICONE IMPLANTS|||||||INAMED/ALLERGAN|||||110||True
3362400|3927432|D|1||I HAD INAMED ALLERGAN SILICONE BREAST IMPLANTS INSERTED ON B6 2007 APPROX 2 WEEKS AGO LATE B6 2013 I NOTICED A PALPABLE MASS IN MY LEFT AXILLA LYMPH NODES MY OBGYN CONFIRMED CAUSE FOR CONCERN AND INSTRUCTED ME TO HAVE A MAMMOGRAM AND SONOGRAM TO DETERMINE CAUSE OF THE MASS ON B6 2013 RADIOLOGIST CONFIRMED A HIGHLY ECHOGENIC MASS VIA SONOGRAM 21CM X 14CM X 5MM IN SIZE AND RECOMMENDED NEEDLE BIOPSY TO CONFIRM PATHOLOGY NEEDLE BIOPSY ON B6 2013 CONFIRMED LYMPH NODE CONTAINING FOREIGN BODY REACTION TO REFRACTILE NON-POLARIZABLE MATERIAL CONSISTENT WITH SILICONE CONSULTATION WITH TWO PLASTIC SURGEONS ORIGINAL SURGEON AND A SECOND OPINION CONFIRM IN THEIR OPINION EXTRA-CAPSULAR RUPTURE IN LEFT SIDE WHERE LUMP IS AND POSSIBLE INTRA-CAPSULAR OR EXTRA-CAPSULAR RUPTURE IN RIGHT SIDE AS WELL DENSE LYMPH NODES WERE ALSO NOTED ON THAT SIDE IN THE SONOGRAM BUT NOT AS LARGE AS ON THE LEFT I AM CONCERNED THAT I WOULD HAVE THIS TYPE OF COMPLICATION ONLY 6 YEARS AFTER INSERTION AND FELT IT SHOULD BE REPORTED|SILICONE IMPLANTS|110-240|09/17/2013|||||||0LP|FTR|2.0||SILICONE IMPLANTS|||||||INAMED/ALLERGAN|||||110||True
3523577|19486817|D|1||HEALTH PROFESSIONAL REPORTED A CASE OF ALCL APPROX B6 2013 THE PT COMPLAINED OF A LEFT SIDE DEFLATION ONCE EXAMINED IT WAS NOTED THAT IT WAS THE RIGHT BREAST THAT WAS ENLARGING IN REVIEWING A MAMMOGRAM PERFORMED IN B6 2013 FLUID WAS SEEN BEHIND THE CAPSULE THE PT WAS SENT FOR AN MRI WHICH SHOWED AN UPTAKE IN THE CAPSULE THE PT WAS ADMITTED FOR ELEVATED WHITE COUNT AND ABDOMINAL PAIN THE CT OF THE ABDOMEN WAS NEGATIVE AS WELL AS THE CXR THE DIAGNOSIS AT THE TIME OF ADMISSION WAS RIGHT BREAST MASS ASPIRATION WAS PERFORMED RESULTS WERE 5 ATYPICAL CELLS THE PATHOLOGIST PERFORMED A FLOWCYTOMETRY THE DIAGNOSIS OF ALCL WAS MADE WITH THE CAPSULE ALK- THE RESULTS WERE SENT TO THE NIH TO CONFIRM THE DIAGNOSIS A PET SCAN WAS PERFORMED REVEALING ONCE LYMPH NODE WHICH WAS POSITIVE THE SURGEON FEELS THAT THIS WAS DUE TO THE DYE FROM THE MRI AND HE WILL HAVE THE PT UNDERGO ANOTHER IN A FEW WEEKS THE PT HAS SEEN AN ONCOLOGIST THE RADIATION ONCOLOGIST IS DISCUSSING POSSIBLE TREATMENT WITH RADIATION THE SURGEON STATES HE FEELS THIS IS UNNECESSARY ADDL INFO WILL BE SENT IFWHEN IT BECOMES AVAILABLE|STYLE 168 SALINE FILLED BREAST IMPLANT|168-300|12/02/2013|||DA|N|R||0HP|FWM|1.0|03/29/2008|nan||620705|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
3887949|21965949|D|1||FAMILY MEMBER REPORTED PT DEATH NOTING THE CAUSE OF DEATH AS LYMPHOMA THE PT HAD A HISTORY OF RIGHT SIDE BREAST CANCER AND ENDOMETRIAL CANCER SEVERAL ATTEMPTS WERE MADE TO GATHER ADDL INFO REGARDING THE DIAGNOSIS OF LYMPHOMA BUT NO ONE COULD PROVIDE THE INFO REQUESTED THE CORONERS OFFICE WERE ABLE TO CONFIRM THE DATE AND CAUSE OF DEATH BUT NOT THE SPECIFIC TYPE OF LYMPHOMA|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-304|06/03/2014|||DA|N|R||0HP|FTR|1.0|11/11/2012|nan||1528157|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5186386|29786531|D|1||HEALTH PROFESSIONAL REPORTED APPEARANCE OF PERI PROSTHETIC RECIDIVIST LIQUID WHICH AT THE HISTOLOGICAL EXAMINATION RESULTED TO BE COMPATIBLE WITH ANAPLASTIC LARGE CELL LYMPHOMA DEVICE WAS EXPLANTED AND A TOTAL CAPSULECTOMY WAS PERFORMED SIDE WAS UNSPECIFIED EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS ARE RECEIVED TO CONFIRM ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX150-620|10/29/2015||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1325729|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5140583|27949119|N|1||MEDWATCH SUBMITTED TO THE FDA ON 10092015 FOLLOW UP HAS BEEN PERFORMED TO CONFIRM EVENTS AND NO RESPONSE HAS BEEN RECEIVED AT THIS TIME DEVICE LABELING IN ADDITION CONCERNS HAVE BEEN RAISED REGARDING POTENTIAL DAMAGING EFFECTS ON CHILDREN BORN TO MOTHERS WITH IMPLANTS TWO STUDIES IN HUMANS HAVE FOUND THAT THE RISK OF BIRTH DEFECTS OVERALL IS NOT INCREASED IN CHILDREN BORN AFTER BREAST IMPLANT SURGERY ALTHOUGH LOW BIRTH WEIGHT WAS REPORTED IN A THIRD STUDY OTHER FACTORS FOR EXAMPLE LOWER PRE-PREGNANCY WEIGHT MAY EXPLAIN THIS FINDING THIS AUTHOR RECOMMENDED FURTHER RESEARCH ON INFANT HEALTH A REVIEW OF THE EVIDENCE DID NOT FIND THAT OFFSPRING OF WOMEN WITH IMPLANTS WERE AT AN INCREASED RISK FOR ESOPHAGEAL DISORDERS RHEUMATIC DISEASES OR CONGENITAL MALFORMATIONS|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-339|10/09/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1464868|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5270622|32776697|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF HEALTH PROFESSIONAL A DELAYED SEROMA ALCL AND ON AND OFF SWELLING SIDE UNKNOWN EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS ARE RECEIVED TO CONFIRM ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5270622|36726551|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF HEALTH PROFESSIONAL A DELAYED SEROMA ALCL AND ON AND OFF SWELLING SIDE UNKNOWN EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS ARE RECEIVED TO CONFIRM ALCL HEALTH PROFESSIONAL ADDITIONALLY REPORTED ALCL CASE REPORT PATIENT UNDERWENT UNCOMPLICATED BILATERAL BREAST AUGMENTATION WITH MCGHAN STYLE 468 SALINE-FILLED BREAST IMPLANTS PATIENT DID VERY WELL UNTIL PATIENT NOTED INTERMITTENT SWELLING OF THE LEFT BREAST MAMMOGRAM AND ULTRASOUND OF THE LEFT BREAST ORDERED BY THE PCP CONFIRMED PERI-PROSTHETIC SEROMA WITHOUT ANY ABNORMAL BREAST TISSUE FINDINGS THE SWELLING BECAME MORE PERSISTENT AND PATIENT WAS SEEN IN THE OFFICE FOR EVAL AND WAS TAKEN EXPEDIENTLY TO THE OPERATING ROOM FOR SEROMA ASPIRATION CULTURES AND CAPSULE BIOPSY CONFIRMED ALCL CULTURES WERE NEGATIVE ONE WEEK LATER PATIENT UNDERWENT COMPLETE CAPSULECTOMY AND IMPLANT REMOVAL WITHOUT REPLACEMENT|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5270622|33982741|D|1||COMPANY REPRESENTATIVE REPORTED ON BEHALF OF HEALTH PROFESSIONAL A DELAYED SEROMA ALCL AND ON AND OFF SWELLING SIDE UNKNOWN EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS ARE RECEIVED TO CONFIRM ALCL|STYLE 468 SALINE FILLED BREAST IMPLANT|468-300|12/07/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||565193|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5285719|33288643|D|1||COMPANY REPRESENTATIVE REPORTED PHYSICIAN STATED POSSIBLE ALCLNO OTHER SPECIFICS WERE GIVEN TO ME SIDE NOT SPECIFIED MANUFACTURER OF THE DEVICE IS UNKNOWN PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-350|12/10/2015||01/08/2016|DA|R|Y||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5054360|24980550|D|1||PATIENT REPORTED LEFT SIDE SEROMA AND ANAPLASTIC LYMPHOMA DEVICE WAS REMOVED PATIENT ADDITIONALLY REPORTED SAMPLE OF THE CAPSULE WAS TAKEN FROM THE LEFT SIDE AND CAME BACK POSITIVE FOR ANAPLASTIC LYMPHOMA DIAGNOSTIC MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THIS EVENT WILL BE CAPTURED AS LYMPHOMA THESE EVENTS HAVE NOT BEEN CONFIRMED BY A HEALTH PROFESSIONAL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410580|09/03/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429863|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4874726|31122635|D|1||PHYSICIAN REPORTED SUSPICION OF ALCL LYMPHOMA SIDE UNSPECIFIED MANUFACTURER OF THE DEVICE IS UNKNOWN PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED TO CONFIRM ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/26/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4874726|22249899|D|1||PHYSICIAN REPORTED SUSPICION OF ALCL LYMPHOMA SIDE UNSPECIFIED MFR OF THE DEVICE IS UNK PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED TO CONFIRM ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/26/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4874726|54538473|D|1||PHYSICIAN REPORTED SUSPICION OF ALCL LYMPHOMA SIDE UNSPECIFIED MANUFACTURER OF THE DEVICE IS UNKNOWN PATHOLOGICAL MARKERS HAVE NOT BEEN RECEIVED TO CONFIRM ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/26/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4702227|5724962|D|1||HEALTH PROFESSIONAL REPORTED ANAPLASTIC LARGE CELL LYMPHOMA AND PATIENT PRESENTED WITH RIGHT BREAST SWELLING EVENT OF ANAPLASTIC LARGE CELL LYMPHOMA WILL BY CAPTURED AS LYMPHOMA UNTIL DIAGNOSTIC TESTING CAN CONFIRM DIAGNOSIS OF ALCL DEVICE HAS BEEN REMOVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410335|04/16/2015||02/25/2013|DA|Y|Y||0HP|FTR|1.0|02/02/2011|nan||1223847|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4859975|54646975|D|1||HEALTH PROFESSIONAL REPORTED A CASE OF ALCL SIDE UNSPECIFIED MANUFACTURER OF THE DEVICE IS UNKNOWN PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN PROVIDED THEREFORE THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/19/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNKNOWN MANUFACTURER|||||||True
4859975|5810930|D|1||HEALTH PROFESSIONAL REPORTED A CASE OF ALCL SIDE UNSPECIFIED MANUFACTURER OF THE DEVICE IS UNK PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN PROVIDED THEREFORE THE EVENT WILL BE CAPTURED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|06/19/2015|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|LA AURORA DE HEREDIA||NE|CS|UNKNOWN MANUFACTURER|||||||True
5140646|27952496|N|1||FOLLOW UP HAS BEEN PERFORMED TO CONFIRM EVENTS AND NO RESPONSE HAS BEEN RECEIVED AT THIS TIME DEVICE LABELING IN ADDITION CONCERNS HAVE BEEN RAISED REGARDING POTENTIAL DAMAGING EFFECTS ON CHILDREN BORN TO MOTHERS WITH IMPLANTS TWO STUDIES IN HUMANS HAVE FOUND THAT THE RISK OF BIRTH DEFECTS OVERALL IS NOT INCREASED IN CHILDREN BORN AFTER BREAST IMPLANT SURGERY ALTHOUGH LOW BIRTH WEIGHT WAS REPORTED IN A THIRD STUDY OTHER FACTORS FOR EXAMPLE LOWER PRE-PREGNANCY WEIGHT MAY EXPLAIN THIS FINDING THIS AUTHOR RECOMMENDED FURTHER RESEARCH ON INFANT HEALTH A REVIEW OF THE EVIDENCE DID NOT FIND THAT OFFSPRING OF WOMEN WITH IMPLANTS WERE AT AN INCREASED RISK FOR ESOPHAGEAL DISORDERS RHEUMATIC DISEASES OR CONGENITAL MALFORMATIONS|STYLE 15 SILICONE GEL FILLED BREAST IMPLANT|15-339|10/09/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1464868|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4957654|55248981|D|1||ADDITIONAL INFORMATION PROVIDED BY HEALTHCARE PROFESSIONAL NOTES DIAGNOSTIC INFORMATION REPORTED CD30+ AND ALK- PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE BEEN RECEIVED PATIENT HAS SINCE RECEIVED B4 ROUNDS OF CHOEP TREATMENT B6 2015-B6 2016 B4 ROUNDS OF GDP TREATMENT B6 2016-B6 2016 AND B4 ROUNDS OF BRENTUXIMAB STARTING B6 2016 UNTIL PRESENT A STEM CELL TRANSPLANT IS PLANNED FOR B6 2016|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4702205|15310134|D|1||HEALTH PROFESSIONAL REPORTED TO REGULATORY AGENCY VIA VOLUNTARY MW5039346 ALCL CASE REPORT ASSOCIATED WITH BREAST CANCER RECONSTRUCTION PATIENT FOLLOW-UP REVEALS THAT PATIENT HAS A HISTORY OF LEFT BREAST DUCTAL CARCINOMA IN SITU PRIOR TO BREAST IMPLANTS THE PATIENT PRESENTED WITH SWELLING AND PAIN PRIMARY DIAGNOSIS OF ALCL WAS DIAGNOSED AGAINST THE RIGHT SIDE IN THE PERI IMPLANT FLUID AND 1 X 23 CM MASS AT MEDIANINFERIOR EDGE OF IMPLANT THE SEROMA WAS NOTED AS SEVERE PATIENT WAS TREATED WITH CHEMOTHERAPY AND THE RIGHT SIDE DEVICE WAS EXPLANTED PATHOLOGY RESULTS CONFIRM THE DIAGNOSIS SHOULD READ AS BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IMMUNOSTAINS SHOW TUMOR CELLS ARE POSITIVE FOR CD30 CD2 AND CD4 THEY ARE NEGATIVE FOR ER PR HER2 AND CYTOKERATIN S100 CD45 MPO CD3 CD20 AND ALK1|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|04/16/2015|||DA|N|R||0HP|FWM|1.0|12/05/2008|nan||1059645|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5338604|34795715|N|1||THE EVENT OF CAPSULAR CONTRACTURE IS A PHYSIOLOGICAL COMPLICATION AND THE ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE OF THIS EVENT DEVICE LABELING ADDRESSES THE REPORTED EVENT OF CAPSULAR CONTRACTURE AS FOLLOWS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL DEVICE DETAIL IS NOT ATTAINABLE|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-280|12/31/2015||10/22/2015||R|Y||0HP|FTR|1.0|05/23/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1619834|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4385749|15814629|D|1||HEALTH PROFESSIONAL REPORTED DIAGNOSIS OF ANAPLASTIC LYMPHOMA LINKED TO BREAST PROSTHESIS PLACED FOR BREAST RECONSTRUCTION DIAGNOSTIC TESTS NOT PROVIDED TO CONFIRM ALCL THE EVENT OF LYMPHOMA WILL BE REPORTED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FX115-315|12/24/2014|||DA|N|R||0HP|FTR|1.0|08/25/2012|nan||1474756|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5286954|40348295|N|1||MEDWATCH SENT TO FDA ON 3142016 THE PHYSICIAN DID NOT CONFIRM WHETHER THE DEVICE WAS EXPLANTED BUT DID CONFIRM THAT THE DEVICE WOULD NOT BE RETURNED THEREFORE NO ANALYSIS OR TESTING WILL BE DONE THESE EVENTS ARE BEING REPORTED BECAUSE MEDICAL INTERVENTION WAS REQUIRED ALTHOUGH DEVICE-RELATEDNESS HAS NOT BEEN ESTABLISHED THE EVENTS OF SEROMA GRANULOMATOUS REACTION AND LIPOPHAGIC NECROSIS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL -- INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF THE REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION INFLAMMATORY REACTION STUDIES EVALUATING THE CAPSULES AROUND TEXTURED IMPLANTS HAVE REPORTED POSSIBLE SILICONE PARTICLES WITHIN GIANT CELLS INDICATIVE OF A LOCAL AND NONSPECIFIC FOREIGN BODY REACTION AND SILICONE GRANULOMA FORMATION IN CASE OF AN INFLAMMATORY REACTION THE SURGEON IS ADVISED TO REMOVE THE DEVICE FROM THE PATIENTS BODY AND TO SECURE ANY EVIDENCE ON THE POSSIBLE CAUSE OF THE INFLAMMATORY REACTION AND TO TREAT THE PATIENT CORRESPONDINGLY IT IS ADVISED NOT TO REPLACE THE IMPLANT UNTIL THE INFLAMMATORY REACTION HAS PASSED COMPLETELY AND ITS CAUSE HAS BEEN ELIMINATED NECROSIS NECROSIS MAY INHIBIT WOUND HEALING AND REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION PERMANENT SCAR DEFORMITY MAY OCCUR AS A RESULT OF NECROSIS DO NOT USE MICROWAVE DIATHERMY IN PATIENTS WITH BEAST IMPLANTS MICROWAVE DIATHERMY HAS BEEN REPORTED TO CAUSE TISSUE NECROSIS SKIN EROSION AND IMPLANT EXTRUSION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4665224|5729407|D|1||REPORTED AS LYMPHADENOPATHYEXTRAVASATION ADDITIONAL REPORT STATES LEVY MICROBIOLOGY OF LEFT BREAST AND ANAPATH ON EXERESE OF LEFT DEVICE BREAST CAPSULE PERIPROSTHETIC BREAST CAPSULE HAVING ON ITS SIDE INTRACAPSULAR INFILTRATION BY CD30 + ALCL EMA + AS PATHOLOGY HAS NOT BEEN RECEIVED TO CONFIRM ALCL THIS EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120341|04/06/2015||07/14/2014|DA|Y|Y||0HP|FTR|1.0|12/09/2010|NONE||1178535|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4672656|5689022|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE DEVICE REMOVED DUE TO PTS REPORT OF SWOLLEN AND TIGHT FEELING HEALTH PROFESSIONAL NOTED A YELLOW CLEAR FLUID WAS DRAINED AND PATHOLOGY SHOWED CYTOLOGIC FEATURES CONSISTENT WITH ATYPICAL CELLS UPON REMOVAL DEVICE WAS NOTED TO BE UPSIDE DOWN AND THE LEFT BREAST CAPSULE HAD MALIGNANT CELLS THAT WERE FOCALLY INFILTRATING THE CAPSULAR SURFACE WITH ASSOCIATED NECROSIS PATHOLOGY RESULTS CONFIRM ANAPLASTIC LARGE CELL LYMPHOMA STRONG POSITIVE FOR CD30+|STYLE 163 SALINE FILLED BREAST IMPLANT|163-530|04/08/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5092043|26351218|D|1||EXPLANTING PHYSICIAN REPORTED CAPSULE CONFINED ALCL SPECIFIED AS RIGHT SIDE DEVICE HAS BEEN EXPLANTED NO POSTOPERATIVE COMPLICATIONS EVENT CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS TO CONFIRM ALCL ARE RECEIVED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|09/21/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5339043|34879104|N|1||THE EVENT OF CAPSULAR CONTRACTURE IS A PHYSIOLOGICAL COMPLICATION AND THE ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE OF THIS EVENT DEVICE LABELING ADDRESSES THE REPORTED EVENT OF CAPSULAR CONTRACTURE AS FOLLOWS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL DEVICE DETAIL IS NOT ATTAINABLE|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-280|12/31/2015||10/22/2015||R|Y||0HP|FTR|1.0|03/23/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1588966|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6177062|62452555|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL SEROMA BREAST LUMPS AND ERYTHEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6145451|61448261|D|1||PHYSICIAN REPORTED A PATIENT WITH A LATE SEROMA ON THE RIGHT SIDE CYTOLOGICAL EXAMINATION RESULTED IN ALCL DIAGNOSIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM120-280|12/05/2016||||N|R||0HP|FTR|1.0|06/13/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1287540|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145451|61448260|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED FOR DEVICE RETURN IF DEVICE IS RETURNED ANALYSIS WILL BE PERFORMED AND RESULTS REPORTED IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE HISTORY RECORD DHR WAS PERFORMED AND DID NOT IDENTIFY ANY DEVIATIONS ERRORS OR OMISSIONS DURING MANUFACTURING PROCESS ACCORDING TO THE INFORMATION GATHERED DURING THE DHR REVIEW THERE IS ENOUGH EVIDENCE TO SUPPORT THAT DEVICES FROM THIS WORK ORDER WERE ASSEMBLED IN ACCORDANCE WITH ALLERGAN MEDICAL PROCEDURES AND SPECIFICATIONS THE REPORTED DEVICE WAS INTACT AT THE TIME OF PRODUCTION AND MET THE REQUIRED SPECIFICATIONS REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM120-280|12/05/2016||||N|R||0HP|FTR|1.0|06/13/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1287540|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5691027|51422386|D|1||PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410215|06/01/2016|||DA|N|R||0HP|FTR|1.0|06/02/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1620541|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5691027|46273891|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE REMOVAL AND REPLACEMENT DUE TO LATE SEROMA COMPANY REPRESENTATIVE REPORTED ON BEHALF OF PHYSICIAN SENT SEROMA FLUID AND CAPSULE TISSUE TO PATHOLOGY TO TEST FOR ALCL AND THE DOCTOR REPORTED THE TEST CAME BACK POSITIVE COMPANY REPRESENTATIVE ADDITIONALLY REPORTED ON BEHALF OF PHYSICIAN DISEASE SHOWED ON PATHOLOGY IN SEROMA FLUID AND IN CAPSULE PARTIAL CAPSULECTOMY WAS DONE INTRAOP AND IMPLANT WAS REPLACED PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT YET BEEN RECEIVED EVENT WILL BE CAPTURED AS LYMPHOMA AT THIS TIME|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MM-410215|06/01/2016|||DA|N|R||0HP|FTR|1.0|06/02/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1620541|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5644586|48310176|D|1||HEALTH PROFESSIONAL REPORTED ONE OF THE ALCL PATIENTS HAD FURTHER SURGERY TO REMOVE THEIR REPLACEMENT IMPLANT AND THE NEW CAPSULE THUS HAS COME BACK POSITIVE FOR ALCL SPECIFIED AS RIGHT SIDE THIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5644586|44853450|D|1||HEALTH PROFESSIONAL REPORTED ONE OF THE ALCL PATIENTS HAD FURTHER SURGERY TO REMOVE THEIR REPLACEMENT IMPLANT AND THE NEW CAPSULE THUS HAS COME BACK POSITIVE FOR ALCL SPECIFIED AS RIGHT SIDE THIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5644586|47903123|D|1||HEALTH PROFESSIONAL REPORTED ONE OF THE ALCL PATIENTS HAD FURTHER SURGERY TO REMOVE THEIR REPLACEMENT IMPLANT AND THE NEW CAPSULE THUS HAS COME BACK POSITIVE FOR ALCL SPECIFIED AS RIGHT SIDE THIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6177002|62447626|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6210742|63447030|N|1||ARTICLE CITATION Â¿INCIDENCE OF BREAST IMPLANT RUPTURE IN A 12-YEAR RETROSPECTIVE COHORT EVIDENCE OF QUALITY DISCREPANCY DEPENDING ON THE RANGEÂ¿ BY FREDERIC SEIGLE-MURANDI FRANCOIS LEFEBVRE CATHERINE BRUANT-RODIER FREDERIC BODIN PUBLISHED IN JOURNAL OF PLASTIC RECONSTRUCTIVE  AESTHETIC SURGERY VOLUME 70  ISSUE 1  42 - 46 PUBLISHED ONLINE 11102016 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENT IS ADDRESSED IN DEVICE LABELING GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MLP-230|12/28/2016|||DA|*|*||0HP|FTR|1.0|03/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||281480|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5350082|35218430|N|1||THE EVENT OF CAPSULAR CONTRACTURE IS A PHYSIOLOGICAL COMPLICATION AND THE ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE OF THIS EVENT DEVICE LABELING ADDRESSES THE REPORTED EVENT OF CAPSULAR CONTRACTURE AS FOLLOWS POTENTIAL ADVERSE EVENTS THAT MAY OCCUR WITH SILICONE GEL FILLED BREAST IMPLANT SURGERY INCLUDE IMPLANT RUPTURE CAPSULAR CONTRACTURE REOPERATION IMPLANT REMOVAL PAIN CHANGES IN NIPPLE AND BREAST SENSATION INFECTION SCARRING ASYMMETRY WRINKLING IMPLANT DISPLACEMENTMIGRATION IMPLANT PALPABILITYVISIBILITY BREASTFEEDING COMPLICATIONS HEMATOMASEROMA IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS AND LYMPHADENOPATHY ALLERGAN IS UNABLE TO CONFIRM WITH THE HEALTHCARE PROFESSIONAL THEREFORE ADDITIONAL DEVICE DETAIL IS NOT ATTAINABLE|STYLE 10 SILICONE GEL FILLED BREAST IMPLANT|10-300|01/07/2016||10/22/2015|DA|R|Y||0HP|FTR|1.0|07/01/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1469024|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6210833|63437200|N|1||ARTICLE CITATION Â¿INCIDENCE OF BREAST IMPLANT RUPTURE IN A 12-YEAR RETROSPECTIVE COHORT EVIDENCE OF QUALITY DISCREPANCY DEPENDING ON THE RANGEÂ¿ BY FREDERIC SEIGLE-MURANDI FRANCOIS LEFEBVRE CATHERINE BRUANT-RODIER FREDERIC BODIN PUBLISHED IN JOURNAL OF PLASTIC RECONSTRUCTIVE  AESTHETIC SURGERY VOLUME 70  ISSUE 1  42 - 46 PUBLISHED ONLINE 11102016 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENT IS ADDRESSED IN DEVICE LABELING GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TRL230|12/28/2016|||DA|*|*||0HP|FTR|1.0|12/13/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1691512|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176674|62457390|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL SEROMA AND MASS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6142978|61395222|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND DEATH ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6153182|61700300|N|1||B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHADENOPATHY AND LYMPHOMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5644581|44885547|D|1||HEALTH PROFESSIONAL REPORTED A RIGHT SIDE DEVICE REMOVAL AND TOTAL CAPSULECTOMY FOLLOWING SEROMA AND DIAGNOSIS OF ALCL MANUFACTURER OF THE DEVICE IS UNKNOWN THIS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/10/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||nan|||||||True
6199283|63133499|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF LYMPHOMA IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT AND PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM130-360|12/22/2016|||DA|N|R||0HP|FTR|1.0|11/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||352966|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6023404|72695628|D|1||PHYSICIAN REPORTS PATIENT WITH SUDDEN ONSET OF SEROMA ON RIGHT SIDE PHYSICIAN REPORTED IMPLANT WAS REMOVED AS PART OF TOTAL CAPSULECTOMY AND DIAGNOSIS OF IA LCAL WAS MADE ON CYTOLOGY OF THE ASPIRATED SEROMA FLUID EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FX155-775|10/12/2016||03/02/2017|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2379964|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN (COSTA RICA)|||||||True
6023404|57191543|D|1||PHYSICIAN REPORTS PATIENT WITH SUDDEN ONSET OF SEROMA ON RIGHT SIDE PHYSICIAN REPORTED IMPLANT WAS REMOVED AS PART OF TOTAL CAPSULECTOMY AND DIAGNOSIS OF IA LCAL WAS MADE ON CYTOLOGY OF THE ASPIRATED SEROMA FLUID EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FX155-775|10/12/2016||03/02/2017|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2379964|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN (COSTA RICA)|||||||True
6210566|63428797|N|1||ARTICLE CITATION Â¿INCIDENCE OF BREAST IMPLANT RUPTURE IN A 12-YEAR RETROSPECTIVE COHORT EVIDENCE OF QUALITY DISCREPANCY DEPENDING ON THE RANGEÂ¿ BY FREDERIC SEIGLE-MURANDI FRANCOIS LEFEBVRE CATHERINE BRUANT-RODIER FREDERIC BODIN PUBLISHED IN JOURNAL OF PLASTIC RECONSTRUCTIVE  AESTHETIC SURGERY VOLUME 70  ISSUE 1  42 - 46 PUBLISHED ONLINE 11102016 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENT IS ADDRESSED IN DEVICE LABELING GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM125-320|12/28/2016|||DA|*|*||0HP|FTR|1.0|06/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||154938|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5904549|58060034|D|1||PHYSICIAN REPORTED THE RIGHT BREAST WAS SWOLLEN FIRM AND SENSITIVE TO DEEP PALPATION PHYSICIAN ALSO STATED AN ANAPLASTIC LARGE CELL LYMPHOMA WAS FOUND IN THE PERI PROSTHETIC FLUID AND FIBRINOID DEPOSITS WITHIN THE PERIPROSTHETIC CAPSULE OF THE RIGHT BREAST PHYSICIAN ALSO STATED THE PT UNDERWENT BILATERAL TOTAL CAPSULECTOMY AND IMPLANT REMOVAL NOW MORE THAN A YEAR AFTER THE PT IS DISEASE FREE CT PET SCANS INCLUDING A RECENT SCAN DO NOT SHOW ANY SIGNS OF THE LYMPHOMA EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5904549|53036937|D|1||PHYSICIAN REPORTED THE RIGHT BREAST WAS SWOLLEN FIRM AND SENSITIVE TO DEEP PALPATION PHYSICIAN ALSO STATED AN ANAPLASTIC LARGE CELL LYMPHOMA WAS FOUND IN THE PERI PROSTHETIC FLUID AND FIBRINOID DEPOSITS WITHIN THE PERIPROSTHETIC CAPSULE OF THE RIGHT BREAST PHYSICIAN ALSO STATED THE PT UNDERWENT BILATERAL TOTAL CAPSULECTOMY AND IMPLANT REMOVAL NOW MORE THAN A YEAR AFTER THE PT IS DISEASE FREE CT PET SCANS INCLUDING A RECENT SCAN DO NOT SHOW ANY SIGNS OF THE LYMPHOMA EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5884313|52381107|D|1||REPORTED EVENTS FOUND WITHIN THE FOLLOWING ARTICLE CANCER RISK OF BREAST IMPLANTS 10 TIMES HIGHER THAN FIRST FEARED SHOCK WARNING FROM SURGEONS  AS ONE BRITISH SURVIVOR RELIVES ORDEAL PATIENT REPORTED DISCOVERED A LUMP THE SIZE OF A 5P PIECE AT THE TOP OF RIGHT BREAST NEAR THE CLEAVAGE PATIENT REPORTED DIAGNOSIS OF ALCL VIA ULTRASOUND SCAN AND NEEDLE BIOPSY PATIENT RECEIVED CHEMOTHERAPY TREATMENT PATIENT ALSO REPORTED MY RIGHT BREAST WAS SWOLLEN FELT BURNING HOT AND I HAD DEVELOPED A RED ITCHY RASH I BECAME UNABLE TO RAISE MY RIGHT ARM TO BRUSH MY HAIR OR TEETH AND COULD NO LONGER COOK OR DRIVE PATIENT RECEIVED SEVEN CYCLES OF BRENTUXIMAB DEVICE WAS THEN REMOVED PATIENT HAS BEEN TOLD THERE IS NO REMAINING CANCER EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5595588|43273265|D|1||HEALTH PROFESSIONAL REPORTED PATIENT PRESENTED WITH LATE ONSET SEROMA WHICH TESTED POSITIVE FOR ALCL PATIENT HAS HAD IMPLANT REMOVED AND TOTAL CAPSULECTOMY OF THE RIGHT SIDE IMPLANT AND CAPSULE HAS BEEN SENT FOR HISTOLOGY PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT YET BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF140-535|04/21/2016||||N|R||0HP|FTR|1.0|09/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||165721|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5690994|49507692|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DIAGNOSED WITH ALCL DISEASE ASSOCIATED TO BREAST DEVICE SIDE UNSPECIFIED EXPLANT AND CAPSULECTOMY PERFORMED THE EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110391|06/01/2016|||DA|N|R||0HP|FTR|1.0|03/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||201218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5690994|46271113|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DIAGNOSED WITH ALCL DISEASE ASSOCIATED TO BREAST DEVICE SIDE UNSPECIFIED EXPLANT AND CAPSULECTOMY PERFORMED THE EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110391|06/01/2016|||DA|N|R||0HP|FTR|1.0|03/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||201218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6210684|63434758|N|1||ARTICLE CITATION Â¿INCIDENCE OF BREAST IMPLANT RUPTURE IN A 12-YEAR RETROSPECTIVE COHORT EVIDENCE OF QUALITY DISCREPANCY DEPENDING ON THE RANGEÂ¿ BY FREDERIC SEIGLE-MURANDI FRANCOIS LEFEBVRE CATHERINE BRUANT-RODIER FREDERIC BODIN PUBLISHED IN JOURNAL OF PLASTIC RECONSTRUCTIVE  AESTHETIC SURGERY VOLUME 70  ISSUE 1  42 - 46 PUBLISHED ONLINE 11102016 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENT IS ADDRESSED IN DEVICE LABELING GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|12/28/2016|||DA|N|R||0HP|FTR|1.0|06/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||152687|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5956972|54992703|D|1||PHYSICIAN REPORTS PATIENT UNDERWENT DELAYED RECONSTRUCTION NO PROBLEMS UNTIL 2015 WHEN PATIENT DEVELOPED A SPONTANEOUS HEAMO-SEROUS FLUID COLLECTION AROUND THE IMPLANT THIS FILE IS FOR THE LEFT SIDE DEVICE WAS REMOVED AND REPLACED FURTHER REPORT STATES IMPLANT APPEARED PREDOMINANTLY INTACT BUT TINY IRREGULARITY IDENTIFIED AND IMPLANT WAS THEREFORE REPLACED LARGE BLOOD STAINED FLUID COLLECTION RECURRED IN 2016 LEADING TO FURTHER EXPLORATION AND FIBRINOUS TISSUE WAS REMOVED AND SENT FOR HISTOLOGY DIAGNOSIS OF ALCL CONFIRMED BY EXPERT HAEMATOLOGY PANEL PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED THEREFORE THIS EVENT WILL BE CAPTURED AS LYMPHOMA|STYLE 150 EXPANDABLE BREAST IMPLANT|27-150496|09/16/2016|||DA|N|R||0HP|FTR|1.0|02/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1205583|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6180550|62543961|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP IS BEING PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENT OF LYMPHOMA IS PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS HAS BEEN REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/16/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6177211|62456167|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL SEROMA LUMP AND ERYTHEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5788476|53800763|D|1||HEALTH PROFESSIONAL REPORTED BREAST VOLUME INCREASE 5 YEARS AFTER REPLACEMENT AS PART OF MAMMARY MASTECTOMY PERIPROSTHETIC EXTRAVASATION REMOVAL OF PROSTHESIS + TOTAL CAPSULECTOMY ANAPATH RESULTS ALCL CONFIRMED SIDE WAS NOT SPECIFIED FURTHER INFORMATION RECEIVED REPORTS INCREASE OF THE VOLUME OF THE LEFT BREAST WITH EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK WITHOUT REDNESS NO PAIN OR FEVER IMPLANT REMOVAL AND TOTAL CAPSULECTOMY THE IMPLANT WAS FOUND INTACT A SAMPLE IS TAKEN AND DIAGNOSIS OF ALCL AIM CD30+ ALK- WILL BE DONE BY HISTOLOGICAL ANALYSIS CONFIRMED BY THE NETWORK LYMPHOPATH PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5788476|51513752|D|1||FURTHER INFORMATION RECEIVED REPORTS INCREASE OF THE VOLUME OF THE LEFT BREAST WITH EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK WITHOUT REDNESS NO PAIN OR FEVER IMPLANT REMOVAL AND TOTAL CAPSULECTOMIE THE IMPLANT WAS FOUND INTACT A SAMPLE IS TAKEN AND DIAGNOSIS OF ALCL AIM CD30+ ALK- WILL BE DONE BY HISTOLOGICAL ANALYSIS CONFIRMED BY THE NETWORK LYMPHOPATH PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5788476|49361322|D|1||HEALTH PROFESSIONAL REPORTED BREAST VOLUME INCREASE 5 YEARS AFTER REPLACEMENT AS PART OF MAMMARY MASTECTOMY PERIPROSTHETIC EXTRAVASATION REMOVAL OF PROSTHESIS + TOTAL CAPSULECTOMY ANAPATH RESULTS ALCL CONFIRMED SIDE WAS NOT SPECIFIED PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176804|62446182|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6148888|61547075|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN A PATIENT WITH LI-FRAUMENI SYNDROMEÂ¿ BY YI-SHAN LEE ARMANDO FILIE DIANE ARTHUR ANTONIO T FOJO AND ELAINE S JAFFE PUBLISHED IN HISTOPATHOLOGY 67 923Â¿935 IN 2015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA CANCER AND LYMPHOMA-ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6148913|61548011|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA IN A PATIENT WITH LI-FRAUMENI SYNDROMEÂ¿ BY YI-SHAN LEE ARMANDO FILIE DIANE ARTHUR ANTONIO T FOJO AND ELAINE S JAFFE PUBLISHED IN HISTOPATHOLOGY 67 923Â¿935 IN 2015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE CANCER IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6176705|62451142|N|1||B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176730|62445769|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6176886|62453116|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA SEROMA AND MASS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6146425|61492493|D|1||JOURNAL ARTICLE Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA A CASE REPORT AND LITERATURE REVIEWÂ¿ ABSTRACT STATES Â¿PATIENT PRESENTED WITH SEVERAL WEEKS OF PAIN AND FIRMNESS IN PATIENT RIGHT BREAST MRI AND ULTRASOUND DEMONSTRATED A PERI-IMPLANT FLUID COLLECTION ULTRASOUND-GUIDED ASPIRATION REVEALED ANAPLASTIC LARGE CELL LYMPHOMA THE PATIENT WAS TREATED WITH IMPLANT REMOVAL ALONE AND HAS NOW BEEN IN REMISSION FOR 3 YEARSÂ¿ PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT YET BEEN RECEIVED THEREFORE THE EVENT WILL BE REPORTED AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/05/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6176855|62446706|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6176798|62453768|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6143087|61396766|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND LUMPNODULE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6177272|62460334|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6139636|61290117|N|1||IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP HAS BEEN PERFORMED AND DEVICE WILL NOT BE RETURNED IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT IN A SUPPLEMENTAL REPORT EVENT OF HEMATOMA WAS PREVIOUSLY REPORTED VIA RESPONSIVE PSR ON B6 2016 THE EVENTS OF LATE SEROMA AND LYMPHOMA-ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRLP250|12/01/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429970|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176870|62452743|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6139164|61260978|N|1||ARTICLE CITATION Â¿MARKED EOSINOPHILIA AS INITIAL PRESENTATION OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ BY NICOLA OROFINO FRANCESCA GUIDOTTI DANIELE CATTANEO MARIARITA SCIUMÃ UMBERTO GIANELLI AGOSTINO CORTELEZZI  ALESSANDRA LURLO PUBLISHED IN LEUKEMIA  LYMPHOMA PUBLISHED ELECTRONICALLY ON 17MAR2016 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA LYMPHOMA-ALCL PRURITUS AND EOSINOPHILIA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6144474|61423058|N|1||ARTICLE CITATION Â¿WHOLE EXOME SEQUENCING REVEALS ACTIVATING JAK1 AND STAT3 MUTATIONS IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA BY PIERS BLOMBERY ELLA R THOMPSON KATE JONES GISELA MIR ARNAU STEPHEN LADE JOHN F MARKHAM JASON LI ANAND DEVA RICKY W JOHNSTONE AMIT KHOT H MILES PRINCE AND DAVID WESTERMAN PUBLISHED IN HAEMATOLOGICA ELECTRONICALLY PUBLISHED SEPTEMBER 2016 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LATE SEROMA AND LYMPHOMA-ALCL ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176830|62457610|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5803927|49896517|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE DEFLATION DECREASED NIPPLE SENSATION LATE PRESENTING SEROMA AND CAPSULAR CONTRACTURE BAKER GRADE IV TREATMENT HAS OCCURRED PATIENT ADDITIONALLY REPORTED THAT FOLLOWING EXPLANT SURGERY THEY WERE DIAGNOSED WITH ALCL AND STATED THE CANCER DEVELOPED BECAUSE THEY ARE ALLERGIC TO THE PLASTIC HEALTH PROFESSIONAL CONFIRMED THAT THE PATIENT DOES NOT HAVE A CANCER DIAGNOSIS SEPARATE FROM ALCL PATIENT REPORTED THEY EXPERIENCED SWELLING DIMPLING WRINKLING AND TENDERNESS ON AND OFF FOR 10 YEARS EVENT WILL BE CAPTURED AS LYMPHOMA AS PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT YET BEEN RECEIVED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-560|07/19/2016||09/25/2015||R|Y||0HP|FWM|1.0|06/26/2006|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||578468|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6167285|62187249|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND ERYTHEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6143032|61396906|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL AND LATE SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
6167248|62147366|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA ALCL LATE SEROMA AND LUMPNODULE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5460037|39095868|N|1||AS NO PRODUCT WAS RETURNED OR LOT  PROVIDED IT WAS NOT POSSIBLE TO PERFORM A PRODUCT INSPECTION OR REVIEW OF THE PRODUCT HISTORY SHEET MR004 TO CONFIRM IF THE PRODUCT WAS MANUFACTURED WITHIN SPECIFICATION NO CONCLUSION COULD BE DRAWN|HUTCHISON|UNK|01/13/2006|||DA|N|R||0|FWM|1.0||SALINE BREAST IMPLANT||UNK|127 DEERDYKES VIEW|WESTFIELD INDUSTRIAL ESTATE|GLASGOW|UK|BIOSIL LTD.|||||UNK||True
6176648|62440609|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF DEATH LYMPHOMA ALCL SEROMA LUMP AND ERYTHEMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR AS A NORMAL RESPONSE TO EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5896122|52746119|D|1||HEALTHCARE PROFESSIONAL REPORTED ALCL OF AN UNKNOWN SIDE PATIENT HAS BEEN SENT FOR MRI AND PET SCAN NO OTHER INFORMATION IS AVAILABLE AT THIS TIME EVENT WILL BE CAPTURED AS LYMPHOMA UNTIL PATHOLOGICAL MARKERS TO CONFIRM ALCL DIAGNOSIS HAVE BEEN RECEIVED|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/23/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6176965|62446267|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS WITH DIFFERENT OUTCOMESÂ¿ BY C LAURENT A DELAS P GAULARD C HAIOUN A MOREAU L XERRI A TRAVERSE-GLEHEN T ROUSSET I QUINTIN-ROUE T PETRELLA J F EMILE N AMARA P ROCHAIX M P CHENARD-NEU A M TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED IN ANNALS OF ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 IT WAS NOT POSSIBLE TO FULLY INVESTIGATE OR CONFIRM THE ALLEGED EVENT AS THE PRODUCT WAS NOT RETURNED TO ALLERGAN FOR ANALYSIS FOLLOW-UP WILL BE PERFORMED TO REQUEST DEVICE RETURN IF DEVICE IS RETURNED IT WILL BE ANALYZED AND RESULTS SENT TO THE FDA IN A SUPPLEMENTAL REPORT THE EVENTS OF LYMPHOMA-ALCL AND SEROMA ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT PRODUCT OR PATIENT DETAILS WILL BE REQUESTED NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME REPORTED EVENTS ARE ADDRESSED IN DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION FROM MEDICAL LITERATURE HAS SUGGESTED A POSSIBLE ASSOCIATION WITHOUT EVIDENCE OF CAUSATION BETWEEN BREAST IMPLANTS AND THE VERY RARE OCCURRENCE OF ALCL IN THE BREAST THE DISEASE IS EXCEPTIONALLY RARE MAY PRESENT AS A LATE OCCURRING PERI-PROSTHETIC SEROMA AND OCCURS IN WOMEN WITH AND WITHOUT BREAST IMPLANTS SPECIFIC TESTING IS NEEDED TO DISTINGUISH ALCL FROM BREAST CANCER THE MAJORITY OF REPORTED CASES HAD AN INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITH OR WITHOUT ADJUVANT THERAPY WHICH IS GENERALLY UNCHARACTERISTIC OF SYSTEMIC ALCL TREATMENT SHOULD BE DETERMINED IN CONSULTATION WITH A HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR IN THE POSTOPERATIVE PERIOD INHIBITING WOUND HEALING OR HAVE DELAYED ONSET EITHER OF WHICH MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE AND SALINE OR GELSALINE IMPLANTS MAY DEFLATE AT ANY TIME AND REQUIRE REPLACEMENT OR REVISION SURGERY AS RUPTURES ARE MOST OFTEN CLINICALLY SILENT A RADIOLOGICAL ASSESSMENT MAY BE REQUIRED TO AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
